Zscaler (ZS) 10-Q 7 Jun 23 2023 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Apr. 30, 2023	May 31, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2023
Document Transition Report	false
Entity File Number	001-38413
Entity Registrant Name	ZSCALER, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1173892
Entity Address, Address Line One	120 Holger Way
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95134
City Area Code	408
Local Phone Number	533-0288
Title of 12(b) Security	Common Stock, $0.001 Par Value
Trading Symbol	ZS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Shares Outstanding		145,891,168
Entity Central Index Key	0001713683
Current Fiscal Year End Date	--07-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 30, 2023	Jul. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,275,297	$ 1,013,210
Short-term investments	693,110	718,129
Accounts receivable, net	376,339	399,745
Deferred contract acquisition costs	103,896	86,210
Prepaid expenses and other current assets	78,608	39,353
Total current assets	2,527,250	2,256,647
Property and equipment, net	222,801	160,633
Operating lease right-of-use assets	68,526	72,357
Deferred contract acquisition costs, noncurrent	232,304	210,792
Acquired intangible assets, net	28,841	31,819
Goodwill	89,192	78,547
Other noncurrent assets	31,798	21,870
Total assets	3,200,712	2,832,665
Current liabilities:
Accounts payable	24,783	26,154
Accrued expenses and other current liabilities	51,209	46,496
Accrued compensation	123,195	111,948
Deferred revenue	1,058,901	923,749
Operating lease liabilities	31,054	26,100
Total current liabilities	1,289,142	1,134,447
Convertible senior notes, net	1,140,840	968,674
Deferred revenue, noncurrent	116,472	97,374
Operating lease liabilities, noncurrent	42,884	50,948
Other noncurrent liabilities	10,100	7,922
Total liabilities	2,599,438	2,259,365
Commitments and contingencies (Note 11)
Stockholders’ Equity
Common stock; $0.001 par value; 1,000,000 shares authorized as of April 30, 2023 and July 31, 2022; 145,874 and 143,038 shares issued and outstanding as of April 30, 2023 and July 31, 2022, respectively	146	143
Additional paid-in capital	1,660,930	1,590,885
Accumulated other comprehensive loss	(102)	(25,850)
Accumulated deficit	(1,059,700)	(991,878)
Total stockholders’ equity	601,274	573,300
Total liabilities and stockholders’ equity	$ 3,200,712	$ 2,832,665

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Apr. 30, 2023	Jul. 31, 2022
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	145,874,000	143,038,000
Common stock, shares outstanding (in shares)	145,874,000	143,038,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022
Income Statement [Abstract]
Revenue	$ 418,800	$ 286,807	$ 1,161,946	$ 772,887
Cost of revenue	95,849	64,022	260,150	173,974
Gross profit	322,951	222,785	901,796	598,913
Operating expenses:
Sales and marketing	236,273	192,132	701,054	520,991
Research and development	92,637	76,578	253,348	210,989
General and administrative	43,486	40,672	131,164	111,833
Restructuring and other charges	6,301	0	6,301	0
Total operating expenses	378,697	309,382	1,091,867	843,813
Loss from operations	(55,746)	(86,597)	(190,071)	(244,900)
Interest income	18,577	949	39,111	1,979
Interest expense	(1,383)	(14,246)	(4,047)	(42,121)
Other expense, net	(809)	(2,001)	(1,531)	(3,434)
Loss before income taxes	(39,361)	(101,895)	(156,538)	(288,476)
Provision (benefit) for income taxes	6,685	(490)	15,123	4,150
Net loss	$ (46,046)	$ (101,405)	$ (171,661)	$ (292,626)
Net loss per share, basic (in dollars per share)	$ (0.32)	$ (0.72)	$ (1.19)	$ (2.08)
Net loss per share, diluted (in dollars per share)	$ (0.32)	$ (0.72)	$ (1.19)	$ (2.08)
Weighted-average shares used in computing net loss per share, basic (in shares)	145,354	141,422	144,442	140,403
Weighted-average shares used in computing net loss per share, diluted (in shares)	145,354	141,422	144,442	140,403

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (46,046)	$ (101,405)	$ (171,661)	$ (292,626)
Available-for-sale securities:
Change in net unrealized gains (losses) on available-for-sale securities	2,817	(7,121)	4,670	(12,532)
Cash flow hedging instruments:
Change in net unrealized gains (losses)	817	(9,304)	10,797	(13,773)
Net realized gains reclassified into net loss	1,301	1,246	10,281	2,477
Net change on cash flow hedges	2,118	(8,058)	21,078	(11,296)
Other comprehensive income (loss)	4,935	(15,179)	25,748	(23,828)
Comprehensive loss	$ (41,111)	$ (116,584)	$ (145,913)	$ (316,454)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jul. 31, 2021			138,662
Beginning balance at Jul. 31, 2021	$ 528,895		$ 139	$ 1,131,006		$ (650)	$ (601,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			814
Issuance of common stock upon exercise of stock options	6,190			6,190
Issuance of common stock under the employee stock purchase plan (in shares)			109
Issuance of common stock under the employee stock purchase plan	11,509			11,509
Vesting of restricted stock units and other stock issuances (in shares)			2,262
Vesting of restricted stock units and other stock issuances	1,703		$ 3	1,700
Stock-based compensation	299,734			299,734
Other comprehensive income (loss)	(23,828)					(23,828)
Net loss	(292,626)						(292,626)
Ending balance (in shares) at Apr. 30, 2022			141,847
Ending balance at Apr. 30, 2022	531,577		$ 142	1,450,139		(24,478)	(894,226)
Beginning balance (in shares) at Jul. 31, 2021			138,662
Beginning balance at Jul. 31, 2021	$ 528,895		$ 139	1,131,006		(650)	(601,600)
Ending balance (in shares) at Jul. 31, 2022	143,038		143,038
Ending balance at Jul. 31, 2022	$ 573,300	$ (169,899)	$ 143	1,590,885	$ (273,738)	(25,850)	(991,878)	$ 103,839
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]
Beginning balance (in shares) at Jan. 31, 2022			141,063
Beginning balance at Jan. 31, 2022	$ 539,367		$ 141	1,341,346		(9,299)	(792,821)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			150
Issuance of common stock upon exercise of stock options	1,319			1,319
Vesting of restricted stock units and other stock issuances (in shares)			634
Vesting of restricted stock units and other stock issuances	0		$ 1	(1)
Stock-based compensation	107,475			107,475
Other comprehensive income (loss)	(15,179)					(15,179)
Net loss	(101,405)						(101,405)
Ending balance (in shares) at Apr. 30, 2022			141,847
Ending balance at Apr. 30, 2022	$ 531,577		$ 142	1,450,139		(24,478)	(894,226)
Beginning balance (in shares) at Jul. 31, 2022	143,038		143,038
Beginning balance at Jul. 31, 2022	$ 573,300	$ (169,899)	$ 143	1,590,885	$ (273,738)	(25,850)	(991,878)	$ 103,839
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	352		352
Issuance of common stock upon exercise of stock options	$ 3,194			3,194
Issuance of common stock under the employee stock purchase plan (in shares)			115
Issuance of common stock under the employee stock purchase plan	11,410			11,410
Vesting of restricted stock units and other stock issuances (in shares)			2,369
Vesting of restricted stock units and other stock issuances	0		$ 3	(3)
Stock-based compensation	329,182			329,182
Other comprehensive income (loss)	25,748					25,748
Net loss	$ (171,661)						(171,661)
Ending balance (in shares) at Apr. 30, 2023	145,874		145,874
Ending balance at Apr. 30, 2023	$ 601,274		$ 146	1,660,930		(102)	(1,059,700)
Beginning balance (in shares) at Jan. 31, 2023			145,087
Beginning balance at Jan. 31, 2023	528,657		$ 145	1,547,203		(5,037)	(1,013,654)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			128
Issuance of common stock upon exercise of stock options	1,090			1,090
Vesting of restricted stock units and other stock issuances (in shares)			659
Vesting of restricted stock units and other stock issuances	0		$ 1	(1)
Stock-based compensation	112,638			112,638
Other comprehensive income (loss)	4,935					4,935
Net loss	$ (46,046)						(46,046)
Ending balance (in shares) at Apr. 30, 2023	145,874		145,874
Ending balance at Apr. 30, 2023	$ 601,274		$ 146	$ 1,660,930		$ (102)	$ (1,059,700)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Cash Flows From Operating Activities
Net loss	$ (171,661)	$ (292,626)
Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation and amortization expense	39,769	29,437
Amortization expense of acquired intangible assets	8,078	6,695
Amortization of deferred contract acquisition costs	71,368	48,793
Amortization of debt discount and issuance costs	2,919	41,043
Non-cash operating lease costs	23,320	18,988
Stock-based compensation expense	322,730	294,745
Amortization (accretion) of investments purchased at a premium (discount)	(3,389)	5,942
Deferred income taxes	158	(521)
Other	(2,087)	649
Changes in operating assets and liabilities, net of effects of business combinations
Accounts receivable	23,005	(15,449)
Deferred contract acquisition costs	(110,566)	(99,062)
Prepaid expenses, other current and noncurrent assets	(29,605)	(10,354)
Accounts payable	(4,079)	2,966
Accrued expenses, other current and noncurrent liabilities	14,861	10,150
Accrued compensation	10,933	9,056
Deferred revenue	154,256	188,595
Operating lease liabilities	(23,603)	(20,273)
Net cash provided by operating activities	326,407	218,774
Cash Flows From Investing Activities
Purchases of property, equipment and other assets	(70,127)	(48,046)
Capitalized internal-use software	(23,962)	(14,167)
Payments for business acquisitions, net of cash acquired	(15,643)	(380)
Purchase of strategic investments	(2,200)	0
Purchases of short-term investments	(740,239)	(810,111)
Proceeds from maturities of short-term investments	748,166	955,279
Proceeds from sale of short-term investments	25,083	0
Net cash provided by (used in) investing activities	(78,922)	82,575
Cash Flows From Financing Activities
Proceeds from issuance of common stock upon exercise of stock options	3,194	6,190
Proceeds from issuance of common stock under the employee stock purchase plan	11,410	11,509
Payment of deferred consideration related to business acquisitions	0	(50)
Other	(2)	(3)
Net cash provided by financing activities	14,602	17,646
Net increase in cash and cash equivalents	262,087	318,995
Cash and cash equivalents at beginning of period	1,013,210	275,898
Cash and cash equivalents at end of period	1,275,297	594,893
Supplemental Disclosure of Cash Flow Information
Cash paid for income taxes, net of tax refunds	6,582	3,917
Cash paid for interest expense	719	719
Non-Cash Activities
Operating lease right-of-use assets obtained in exchange for operating lease obligations, net of terminations	18,737	18,624
Net change in purchased equipment included in accounts payable and accrued expenses	$ 3,120	$ (404)

Business and Summary of Signifi

Business and Summary of Significant Accounting Policies	9 Months Ended
	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business and Summary of Significant Accounting Policies	Business and Summary of Significant Accounting Policies Description of the Business Zscaler, Inc. ("Zscaler," the "Company," "we," "us," or "our") is a cloud security company that developed a platform incorporating core security functionalities needed to enable fast and secure access to cloud resources based on identity, context and organization’s policies. Our solution is a purpose-built, multi-tenant, distributed cloud platform that incorporates the security functionality needed to enable users, applications, and devices to safely and efficiently utilize authorized applications and services based on an organization’s business policies. We deliver our solutions using a software-as-a-service ("SaaS") business model and sell subscriptions to customers to access our cloud platform, together with related support services. We were incorporated in Delaware in September 2007 and conduct business worldwide, with presence in North America, Europe and Asia. Our headquarters are in San Jose, California. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") and applicable regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the applicable required disclosures and regulations of the SEC. Therefore, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's audited consolidated financial statements and related notes in its Annual Report on Form 10-K for the fiscal year ended July 31, 2022 (the "Fiscal 2022 Form 10-K"), as filed with the SEC on September 15, 2022. Interim Unaudited Condensed Consolidated Financial Statements The accompanying condensed consolidated balance sheet as of July 31, 2022 was derived from the audited consolidated financial statements as of that date. The accompanying interim unaudited condensed consolidated financial statements, including the condensed consolidated balance sheet as of April 30, 2023, the condensed consolidated statements of operations for the three and nine months ended April 30, 2023 and 2022, the condensed consolidated statements of comprehensive loss for the three and nine months ended April 30, 2023 and 2022, the condensed consolidated statements of stockholders’ equity for the three and nine months ended April 30, 2023 and 2022 and the condensed consolidated statements of cash flows for the nine months ended April 30, 2023 and 2022 are unaudited. The related financial data and the other financial information disclosed in the accompanying notes to these interim unaudited condensed consolidated financial statements are also unaudited. These interim unaudited condensed consolidated financial statements have been prepared on a basis consistent with our annual consolidated financial statements and, in our opinion, include all normal recurring adjustments necessary to state fairly our quarterly results. The results of operations for the three and nine months ended April 30, 2023 are not necessarily indicative of the results to be expected for our fiscal year ending July 31, 2023 or for any other future fiscal year or interim period. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal-use software development costs, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value and effective interest rate of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the condensed consolidated financial statements. Due to uncertainty in the macroeconomic environment, including effects of COVID-19 and inflation, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained . Fiscal Year Our fiscal year ends on July 31. References to fiscal 2023, for example, refer to our fiscal year ending July 31, 2023. Significant Accounting Polici es Our significant accounting policies are described in the Fiscal 2022 Form 10-K. There have been no significant changes to these policies that have had a material impact on the condensed consolidated financial statements and related notes for the three and nine months ended April 30, 2023 other than for the restructuring and other charges, derivative instruments and convertible senior notes further described below. Restructuring and Other Charges Restructuring and other charges occur when we commit to a restructuring plan, the restructuring plan identifies all significant actions, the period of time to complete the restructuring plan indicates that significant changes to the restructuring plan are not likely and employees who are impacted have been notified of the pending involuntary termination. A restructuring plan generally includes significant actions involving employee-related severance charges, employee-related benefits, stock-based compensation expense related to the modification of equity incentive awards and other charges associated with the restructuring (the "restructuring charges"). Restructuring charges are accrued in the period in which it is probable that the employees are entitled to the restructuring benefits and the amounts can be reasonably estimated. Restructuring charges are recorded within restructuring and other charges in the condensed consolidated statement of operations. The restructuring liability accrued but not paid at the end of the reporting period is included within accrued compensation in the condensed consolidated balance sheets. Derivative Instruments We enter into foreign currency forward contracts, a portion of which we designate as cash flow hedges, in order to manage the volatility of cash flows that relate to our cost of revenues and operating expenses denominated in foreign currencies. Gains or losses related to our cash flow hedges are recorded as a component of accumulated other comprehensive income (loss) ("AOCI") in the condensed consolidated statements of stockholders' equity until the forecasted transaction occurs in earnings. When the forecasted transaction occurs, the related gains and losses are reclassified into earnings within the financial statement line item associated with the underlying hedged transaction. If the underlying hedged transaction does not occur, or it becomes probable that the hedged transaction will not occur, the cumulative unrealized gain or loss is reclassified immediately from AOCI into earnings within the financial statement line item associated with the underlying hedged transaction. We also use interest rate swaps to economically convert a certain tranche of our fixed interest rate convertible senior notes to floating interest rates, in order to match the floating rate nature of a portion of our cash, cash equivalents, and short-term investments. These interest rate swaps are designated as fair value hedges, and changes in fair value of the interest rate swaps offset the changes in fair market value of the convertible senior notes due to benchmark interest rate movements. Gains or losses related to our fair value hedges are included within interest expense in the condensed consolidated statement of operations in the period of change together with the offsetting loss or gain on the hedged item attributed to the risk being hedged. We recognize changes in the fair value of non-designated derivative instruments within other expense, net in the condensed consolidated statements of operations in the same period that the fair value measurement occurs. We measure hedge effectiveness using regression analysis at hedge inception and periodically thereafter. We include time value in our effectiveness assessment. All of our derivative instruments are measured at fair value. We have elected to present the derivative assets and derivative liabilities on a gross basis on the unaudited condensed consolidated balance sheets. Derivative instruments are classified in the condensed consolidated statements of cash flows as cash from operating activities, which reflect the classification of the underlying hedged transactions. Recently Adopted Accounting Pronouncements

Revenue Recognition

Revenue Recognition	9 Months Ended
	Apr. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue Subscription and support revenue is recognized over time and accounted for approximately 97% of our revenue for each of the three and nine months ended April 30, 2023 and 2022, respectively. The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use our cloud platform: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 Amount % Revenue Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except per percentage data) United States $ 212,454 51 % $ 141,109 49 % $ 581,477 50 % $ 379,940 49 % Europe, Middle East and Africa 128,964 31 % 95,933 33 % 370,713 32 % 264,656 34 % Asia Pacific 62,928 15 % 42,003 15 % 172,785 15 % 109,083 14 % Other 14,454 3 % 7,762 3 % 36,971 3 % 19,208 3 % Total $ 418,800 100 % $ 286,807 100 % $ 1,161,946 100 % $ 772,887 100 % The following table summarizes the revenue from contracts by type of customer: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 Amount % Revenue Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except per percentage data) Channel partners $ 383,222 92 % $ 266,258 93 % $ 1,070,744 92 % $ 720,809 93 % Direct customers 35,578 8 % 20,549 7 % 91,202 8 % 52,078 7 % Total $ 418,800 100 % $ 286,807 100 % $ 1,161,946 100 % $ 772,887 100 % Significant Customers No single customer accounted for 10% or more of the total revenue or the total balance of accounts receivable, net in the periods presented. Contract Balances Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are recognized as revenue over the contractual period. Deferred revenue, including current and noncurrent balances, as of April 30, 2023 and July 31, 2022 was $1,175.4 million and $1,021.1 million, respectively. In the nine months ended April 30, 2023 and 2022, we recognized revenue of $802.1 million and $502.1 million, respectively, that was included in the corresponding contract liability balance at the beginning of these periods. Remaining Performance Obligations The typical subscription and support term is one Costs to Obtain and Fulfill a Contract We capitalize sales commission and associated payroll taxes paid to internal sales personnel that are incremental to the acquisition of channel partner and direct customer contracts. These costs are recorded as deferred contract acquisition costs in the condensed consolidated balance sheets. The activity of the deferred contract acquisition costs consisted of the following: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 (in thousands) Beginning balance $ 315,151 $ 234,505 $ 297,002 $ 207,030 Capitalization of contract acquisition costs 46,364 40,549 110,566 99,062 Amortization of deferred contract acquisition costs (25,315) (17,755) (71,368) (48,793) Ending balance $ 336,200 $ 257,299 $ 336,200 $ 257,299 The outstanding balance of the deferred contract acquisition costs consisted of the following: April 30, 2023 July 31, 2022 (in thousands) Deferred contract acquisition costs, current $ 103,896 $ 86,210 Deferred contract acquisition costs, noncurrent 232,304 210,792 Total deferred contract acquisition costs $ 336,200 $ 297,002 Sales commissions accrued but not paid as of April 30, 2023 and July 31, 2022, totaled $33.8 million and $47.2 million, respectively, which are included within accrued compensation in the condensed consolidated balance sheets.

Cash Equivalents and Short-Term

Cash Equivalents and Short-Term Investments	9 Months Ended
	Apr. 30, 2023
Cash and Cash Equivalents [Abstract]
Cash Equivalents and Short-Term Investments	Cash Equivalents and Short-Term Investments Cash equivalents and short-term investments consisted of the following as of April 30, 2023: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 654,195 $ — $ — $ 654,195 U.S. treasury securities 60,030 1 (10) 60,021 U.S. government agency securities 334,421 1 (30) 334,392 Corporate debt securities 49,203 — — 49,203 Total cash equivalents $ 1,097,849 $ 2 $ (40) $ 1,097,811 Short-term investments: U.S. treasury securities $ 64,664 $ 273 $ — $ 64,937 U.S. government agency securities 233,168 37 (5,013) 228,192 Corporate debt securities 402,561 673 (3,253) 399,981 Total short-term investments $ 700,393 $ 983 $ (8,266) $ 693,110 Total cash equivalents and short-term investments $ 1,798,242 $ 985 $ (8,306) $ 1,790,921 Cash equivalents and short-term investments consisted of the following as of July 31, 2022: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 247,613 $ — $ — $ 247,613 U.S. treasury securities 202,778 — (70) 202,708 U.S. government agency securities 135,525 2 (38) 135,489 Corporate debt securities 106,272 — — 106,272 Total cash equivalents $ 692,188 $ 2 $ (108) $ 692,082 Short-term investments: U.S. treasury securities $ 96,089 $ 10 $ (251) $ 95,848 U.S. government agency securities 339,957 6 (6,628) 333,335 Corporate debt securities 293,968 — (5,022) 288,946 Total short-term investments $ 730,014 $ 16 $ (11,901) $ 718,129 Total cash equivalents and short-term investments $ 1,422,202 $ 18 $ (12,009) $ 1,410,211 The amortized cost and fair value of our short-term investments based on their stated maturities consisted of the following as of April 30, 2023: Amortized Fair Value (in thousands) Due within one year $ 356,348 $ 353,380 Due between one to three years 344,045 339,730 Total $ 700,393 $ 693,110 Short-term investments that were in an unrealized loss position as of April 30, 2023 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. government agency securities $ 63,551 $ (49) $ 144,110 $ (4,964) $ 207,661 $ (5,013) Corporate debt securities 85,903 (376) 102,719 (2,877) 188,622 (3,253) Total $ 149,454 $ (425) $ 246,829 $ (7,841) $ 396,283 $ (8,266) Short-term investments that were in an unrealized loss position as of July 31, 2022 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 80,833 $ (251) $ — $ — $ 80,833 $ (251) U.S. government agency securities 230,670 (5,150) 50,134 (1,478) 280,804 (6,628) Corporate debt securities 155,968 (3,947) 71,127 (1,075) 227,095 (5,022) Total $ 467,471 $ (9,348) $ 121,261 $ (2,553) $ 588,732 $ (11,901) We review the individual securities that have unrealized losses in our short-term investment portfolio on a regular basis. We evaluate, among others, whether we have the intention to sell any of these investments and whether it is not more likely than not that we will be required to sell any of them before recovery of the amortized cost basis. Neither of these criteria were met in any period presented. We additionally evaluate whether the decline in fair value of the corporate debt securities below their amortized cost basis is related to credit losses or other factors. Based on this evaluation, we determined that unrealized losses of the above securities were primarily attributable to changes in interest rates and non-credit related factors. Accordingly, we determined that an allowance for credit losses was unnecessary for our short-term investments as of April 30, 2023 and July 31, 2022. As of April 30, 2023 and July 31, 2022, we recorded $5.8 million and $1.3 million, respectively, of accrued interest receivable within prepaid expenses and other current assets in the condensed consolidated balance sheets.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Apr. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements We measure our financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Our money market funds are classified within Level I due to the highly liquid nature of these assets and have quoted prices in active markets. Certain of our investments in available-for-sale securities (i.e., U.S. treasury securities, U.S. government agency securities and corporate debt securities), as well as our assets and liabilities arising from our foreign currency forward contracts and our interest rate swap contracts, are classified within Level II. The fair value of our Level II financial assets and liabilities is determined by using inputs based on non-binding market consensus prices that are primarily corroborated by observable market data or quoted market prices for similar instruments, for substantially the full term of the financial assets and liabilities. Assets and liabilities that are measured at fair value on a recurring basis as of April 30, 2023, consisted of the following: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 654,195 $ 654,195 $ — $ — U.S. treasury securities 60,021 — 60,021 — U.S. government agency securities 334,392 — 334,392 — Corporate debt securities 49,203 — 49,203 — Total cash equivalents $ 1,097,811 $ 654,195 $ 443,616 $ — Short-term investments: U.S. treasury securities $ 64,937 $ — $ 64,937 $ — U.S. government agency securities 228,192 — 228,192 — Corporate debt securities 399,981 — 399,981 — Total short-term investments $ 693,110 $ — $ 693,110 $ — Total cash equivalents and short-term investments $ 1,790,921 $ 654,195 $ 1,136,726 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 10,782 $ — $ 10,782 $ — Foreign currency contracts assets-noncurrent (2) $ 3,479 $ — $ 3,479 $ — Interest rate contracts assets-noncurrent (2) $ 1,002 $ — $ 1,002 $ — Foreign currency contracts liabilities-current (3) $ 2,425 $ — $ 2,425 $ — Foreign currency contracts liabilities-noncurrent (4) $ 359 $ — $ 359 $ — Interest rate contracts liabilities-current (3) $ 1,598 $ — $ 1,598 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 574 $ — $ 574 $ — Foreign currency contracts liabilities-current (3) $ 1,757 $ — $ 1,757 $ — (1) Included within prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Included within other noncurrent assets in the condensed consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Included within other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2022: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 247,613 $ 247,613 $ — $ — U.S. treasury securities 202,708 — 202,708 — U.S. government agency securities 135,489 — 135,489 — Corporate debt securities 106,272 — 106,272 — Total $ 692,082 $ 247,613 $ 444,469 $ — Short-term investments: U.S. treasury securities $ 95,848 $ — $ 95,848 $ — U.S. government agency securities 333,335 — 333,335 — Corporate debt securities 288,946 — 288,946 — Total $ 718,129 $ — $ 718,129 $ — Total cash equivalents and short-term investments $ 1,410,211 $ 247,613 $ 1,162,598 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 178 $ — $ 178 $ — Foreign currency contract assets-noncurrent (2) $ 17 $ — $ 17 $ — Foreign currency contracts liabilities-current (3) $ 10,921 $ — $ 10,921 $ — Foreign currency contracts liabilities-noncurrent (4) $ 588 $ — $ 588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 452 $ — $ 452 $ — Foreign currency contracts liabilities-current (3) $ 3,427 $ — $ 3,427 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets. We did not have transfers between levels of the fair value hierarchy of assets measured at fair value during the periods presented. Refer to Note 10, Convertible Senior Notes, for the carrying amount and estimated fair value of our convertible senior notes as of April 30, 2023 and July 31, 2022.

Property and Equipment and Purc

Property and Equipment and Purchased Intangible Assets	9 Months Ended
	Apr. 30, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment and Purchased Intangible Assets	Property and Equipment and Purchased Intangible Assets Property and equipment consisted of the following: April 30, 2023 July 31, 2022 (in thousands) Hosting equipment $ 259,998 $ 191,037 Capitalized internal-use software 108,556 72,267 Computers and equipment 7,026 6,774 Purchased software 1,311 1,311 Furniture and fixtures 1,032 1,022 Leasehold improvements 7,404 7,339 Total property and equipment, gross 385,327 279,750 Less: Accumulated depreciation and amortization (162,526) (119,117) Total property and equipment, net $ 222,801 $ 160,633 Purchased intangible assets consist of internet protocol (IP) addresses, which are amortized on a straight-line basis over an estimated useful life of 10 years. As of April 30, 2023, their historical cost and accumulated amortization were $8.6 million and $1.4 million, respectively. As of July 31, 2022, their historical cost and accumulated amortization were $6.4 million and $0.8 million, respectively. Purchased intangible assets are included within other noncurrent assets in the condensed consolidated balance sheets. We recognized depreciation and amortization expense on property and equipment and purchased intangible assets of $14.5 million and $10.4 million for the three months ended April 30, 2023 and 2022, respectively, and $39.8 million and $29.4 million for the nine months ended April 30, 2023 and 2022, respectively. Additionally, we recognized stock-based compensation expense on the amortization of capitalized stock-based compensation associated with capitalized internal-use software of $2.2 million and $1.2 million for the three months ended April 30, 2023 and 2022, respectively, and $5.9 million and $3.1 million for the nine months ended April 30, 2023 and 2022, respectively.
Property and Equipment and Purchased Intangible Assets	Property and Equipment and Purchased Intangible Assets Property and equipment consisted of the following: April 30, 2023 July 31, 2022 (in thousands) Hosting equipment $ 259,998 $ 191,037 Capitalized internal-use software 108,556 72,267 Computers and equipment 7,026 6,774 Purchased software 1,311 1,311 Furniture and fixtures 1,032 1,022 Leasehold improvements 7,404 7,339 Total property and equipment, gross 385,327 279,750 Less: Accumulated depreciation and amortization (162,526) (119,117) Total property and equipment, net $ 222,801 $ 160,633 Purchased intangible assets consist of internet protocol (IP) addresses, which are amortized on a straight-line basis over an estimated useful life of 10 years. As of April 30, 2023, their historical cost and accumulated amortization were $8.6 million and $1.4 million, respectively. As of July 31, 2022, their historical cost and accumulated amortization were $6.4 million and $0.8 million, respectively. Purchased intangible assets are included within other noncurrent assets in the condensed consolidated balance sheets. We recognized depreciation and amortization expense on property and equipment and purchased intangible assets of $14.5 million and $10.4 million for the three months ended April 30, 2023 and 2022, respectively, and $39.8 million and $29.4 million for the nine months ended April 30, 2023 and 2022, respectively. Additionally, we recognized stock-based compensation expense on the amortization of capitalized stock-based compensation associated with capitalized internal-use software of $2.2 million and $1.2 million for the three months ended April 30, 2023 and 2022, respectively, and $5.9 million and $3.1 million for the nine months ended April 30, 2023 and 2022, respectively.

Business Combinations

Business Combinations	9 Months Ended
	Apr. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations Canonic Security Technologies Ltd. On February 20, 2023, we completed the acquisition of Canonic Security Technologies Ltd. ("Canonic"), an early-stage technology company incorporated in Israel. We plan to integrate this company's technology into our cloud platform. Pursuant to the terms of the purchase agreement, the aggregate purchase price consideration was approximately $16.5 million in cash. Additionally, certain Canonic employees who became our employees are entitled to receive deferred merger consideration payable in the form of shares of our common stock. These awards are subject to time-based vesting and will be recognized as stock-based compensation expense during the post-combination period. In connection with this acquisition, we completed a valuation of the acquired identifiable assets as of February 20, 2023. The allocation of the purchase price consideration resulted in the recognition of $10.6 million of goodwill and $5.1 million of developed technology. The acquired developed technology was valued using a replacement cost approach, which is based on the cost of a market participant to reconstruct a substitute asset of comparable utility. Goodwill represents the excess of the purchase price paid over the fair value of the net assets acquired and is primarily attributable to the acquired workforce and expected operating synergies. Both goodwill and acquired developed technology are not deductible for income tax purposes. The acquisition related transaction costs were not material and recorded within general and administrative expenses in the three months ended April 30, 2023. The acquisition qualified as a stock transaction for tax purposes. As a result, we recognized a net deferred tax asset for approximately $0.8 million, generated primarily from a deferred tax asset from net operating losses netted with the deferred tax liability from the difference between the tax basis and fair value of the acquired developed technology, which decreased goodwill by the same amount. The allocation of the purchase price consideration consisted of the following: Amount Estimated Useful Life (in thousands) Assets acquired: Cash, cash equivalents and other assets $ 673 Acquired intangible assets: Developed technology 5,100 5 years Deferred tax asset 781 Goodwill 10,645 Total $ 17,199 Liabilities assumed: Accounts payable, accrued expenses and other liabilities $ 692 Total $ 692 Total purchase price consideration $ 16,507 Other Business Combinations During the three months ended January 31, 2022, we completed a business acquisition for a total purchase price consideration of $2.1 million, consisting of $0.4 million paid in cash at closing and the issuance of shares of our common stock with an aggregate fair value of $1.7 million at closing. Additionally, certain former employees of the acquired company who became our employees are entitled to receive additional consideration in the form of shares of our common stock subject to future employment services. These awards are recognized as stock-based compensation expense during the post- combination period. Based on the valuation of the acquired intangible assets, the allocation of the purchase price consideration resulted in the recognition of $1.6 million of developed technology and $0.8 million of goodwill. The developed technology is amortized over its economic useful life of 5.0 years. Goodwill is not expected to be deductible for income tax purposes. The acquisition qualified as a stock transaction for tax purposes. As a result, we recognized a deferred tax liability for approximately $0.4 million, generated primarily from the difference between the tax basis and fair value of the acquired developed technology, which increased goodwill by the same amount. As we had a full valuation allowance as of January 31, 2022, we recorded an income tax benefit as a result of the reduction of the valuation allowance due to the establishment of the deferred tax liability in the condensed consolidated statement of operations for the nine months ended April 30, 2022. Pro Forma Financial Information The pro forma financial information from the above business acquisitions, assuming the acquisition had occurred as of the beginning of the fiscal year prior to the fiscal year of the acquisition, as well as revenue and earnings generated during the current fiscal year, were not material for disclosure purposes.

Goodwill and Acquired Intangibl

Goodwill and Acquired Intangible Assets	9 Months Ended
	Apr. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Acquired Intangible Assets	Goodwill and Acquired Intangible Assets Goodwill Changes in the carrying amount of goodwill for the nine months ended April 30, 2023 consisted of the following:. Amount (in thousands) Balance as of July 31, 2022 $ 78,547 Goodwill acquired 10,645 Balance as of April 30, 2023 $ 89,192 Acquired Intangible Assets Acquired intangible assets consist of developed technology and customer relationships acquired through our business combinations and asset acquisitions. Acquired intangible assets are amortized using the straight-line method over their estimated useful lives. In February 2023, in connection with the acquisition of Canonic, we acquired developed technology with a fair value of $5.1 million with an estimated useful life of 5.0 years. For further information refer to Note 6, Business Combinations. Changes in acquired intangible assets for the nine months ended April 30, 2023 consisted of the following: Gross Carrying Amount Accumulated Amortization Net Carrying Amount July 31, 2022 Additions April 30, 2023 July 31, 2022 Amortization Expense April 30, 2023 July 31, 2022 April 30, 2023 (in thousands) Developed technology $ 48,356 $ 5,100 $ 53,456 $ (18,972) $ (7,522) $ (26,494) $ 29,384 $ 26,962 Customer relationships 3,560 — 3,560 (1,125) (556) (1,681) 2,435 1,879 Total $ 51,916 $ 5,100 $ 57,016 $ (20,097) $ (8,078) $ (28,175) $ 31,819 $ 28,841 Amortization expense of acquired intangible assets for the three and nine months ended April 30, 2023 was $3.0 million and $8.1 million, respectively, and for the three and nine months ended April 30, 2022 was $2.2 million and $6.7 million, respectively. Amortization expense of developed technology and customer relationships is included primarily within cost of revenue and sales and marketing expenses, respectively, in the condensed consolidated statements of operations. Future amortization expense of acquired intangible assets as of April 30, 2023 consisted of the following: Amount Fiscal Year ending July 31, (in thousands) 2023 (remaining three months) $ 2,774 2024 10,515 2025 7,278 2026 5,252 2027 2,428 Thereafter 594 Total $ 28,841

Derivative Instruments

Derivative Instruments	9 Months Ended
	Apr. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments Foreign Currency Forward Contracts As a global business, we are exposed to foreign currency exchange rate risk. Substantially all of our revenue is transacted in U.S. dollars; however, a portion of our cost of revenue and operating expenditures are incurred outside of the United States and are denominated in foreign currencies, making them subject to fluctuations in foreign currency exchange rates. In order to mitigate the impact of foreign currency fluctuations on our future cash flows and earnings, we enter into foreign currency forward contracts, which we designate as cash flow hedges. All cash flow hedges were considered effective during the three and nine months ended April 30, 2023 and 2022. We also use foreign currency forward contracts to mitigate variability in gains and losses generated from the remeasurement of certain monetary assets and liabilities denominated in foreign currencies. The outstanding non-designated derivative instruments are carried at fair value with change in fair value recorded in other expense, net in the condensed consolidated statement of operations in the same period as the changes in fair value from the remeasurement of the underlying assets and liabilities. Cash flows from such derivatives are classified as operating activities. These foreign exchange contracts typically have maturities of approximately one As of April 30, 2023 and July 31, 2022, the total notional amount of our outstanding designated foreign currency forward contracts was $446.1 million and $293.4 million, respectively, and for our outstanding non-designated foreign currency forward contracts was $170.7 million and $126.4 million, respectively. The maximum length of time over which forecasted foreign currency denominated operating expenses are hedged is 24 months. As of April 30, 2023, an estimated $7.4 million of the unrealized losses related to our cash flow hedges are expected to be released into earnings over the next 12 months. Refer to Note 4, Fair Value Measurements, for the fair value of our derivative instruments as reported on the condensed consolidated balance sheet as of April 30, 2023 and July 31, 2022. During the three and nine months ended April 30, 2023 and 2022, changes in the fair value of our non-designated derivative instruments recorded within other expense, net in the condensed consolidated statements of operations, were not material. During the three months ended April 30, 2023 and 2022, we recognized a gain of $0.8 million and a loss of $9.3 million, respectively, in AOCI related to our cash flow hedges. During the nine months ended April 30, 2023 and 2022, we recognized a gain of $10.8 million and a loss of $13.8 million, respectively, in AOCI related to our cash flow hedges. The following table presents information about losses related to our cash flow hedges reclassified from AOCI into the condensed consolidated statement of operations for three and nine months ended April 30, 2023 and 2022 : Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 (in thousands) Classification: Cost of revenue $ 247 $ 66 $ 1,660 $ 136 Sales and marketing 711 1,125 6,764 2,265 Research and development 272 13 1,319 10 General and administrative 71 42 538 66 Total $ 1,301 $ 1,246 $ 10,281 $ 2,477 Our derivative contracts expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the underlying contracts. We mitigate this credit risk by transacting with major financial institutions with high credit ratings and standards. We periodically assess the creditworthiness of our counterparties to ensure they continue to meet our credit quality requirements. We also enter into master netting arrangements, which permit net settlement of transactions with the same counterparty. The potential impact of these rights of set-off associated with our derivative instruments was not material as of April 30, 2023 and July 31, 2022. We are not required to pledge, and are not entitled to receive, cash collateral related to these derivative instruments. We do not enter into derivative contracts for trading or speculative purposes. Interest Rate Swap Contracts During the three months ended April 30, 2023, we entered into interest rate swaps contracts, maturing on July 1, 2025, designated as fair value hedges intended to hedge a portion of our fair value risk exposure due to changing interest rates by economically converting the fixed interest rate of a certain tranche of our convertible senior notes to a floating interest rate. As of April 30, 2023, the carrying amount of the hedged convertible senior notes was $198.5 million and the total notional amount of our outstanding interest rate swaps was $200.0 million. The gains and losses related to changes in the fair value of the interest rate swaps are included within interest expense in the condensed consolidated statement of operations and substantially offset changes in the fair value of the hedged portion of the underlying convertible senior notes that are attributable to the changes in underlying benchmark interest rates. As of April 30, 2023, the cumulative amount of fair value hedge accounting adjustments included in the carrying amount of hedged liabilities was $0.7 million. The following table presents the effect of derivative instruments designated as fair value hedges included within interest expense in the condensed statement of operations, for the three and nine months ended April 30, 2023: Gains (Losses) (in thousands) Interest rate swaps: Hedged items $ 650 Derivatives designated as hedging instruments (596) Total $ 54

Restructuring and Other Charges

Restructuring and Other Charges	9 Months Ended
	Apr. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Other Charges	Restructuring and Other Charges On March 1, 2023, we announced a plan to restructure and reduce our workforce as a part of our planned efforts to streamline operations and to align people, roles, and projects to our strategic priorities. These actions included the reduction of our worldwide headcount by approximately 3%. We expect to incur aggregate non-recurring restructuring charges of approximately $7.0 million. During the three months ended April 30, 2023, we incurred $6.3 million of restructuring charges, consisting of $5.3 million of employee severance and benefit charges and $1.0 million of stock-based compensation expense related to modified equity incentive awards. These charges were recorded within restructuring and other charges in the condensed consolidated statements of operations. As of April 30, 2023, the restructuring liability accrued but not paid totaled $1.0 million , which is included within accrued compensation in the condensed consolidated balance sheets. We expect the remainder of the restructuring charges of approximately $0.7 million to be incurred in the fourth quarter of fiscal 2023. The following table presents the activity of the restructuring liability for the three months ended April 30, 2023: Restructuring Liability (in thousands) Balance as of January 31, 2023 $ — Charges, excluding stock-based compensation expense 5,265 Payments (4,261) Balance as of April 30, 2023 $ 1,004

Convertible Senior Notes

Convertible Senior Notes	9 Months Ended
	Apr. 30, 2023
Debt Disclosure [Abstract]
Convertible Senior Notes	Convertible Senior Notes On June 25, 2020, we issued $1,150.0 million in aggregate principal amount of 0.125% convertible senior notes due 2025 (the “Notes”), including the exercise in full by the initial purchasers of the Notes of their option to purchase an additional $150.0 million principal amount of the Notes. The Notes are unsecured obligations and bear interest at a rate of 0.125% per year and interest is payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2021. The Notes mature on July 1, 2025, unless earlier converted, redeemed or repurchased. The total net proceeds from the offering, after deducting initial purchase discounts and other debt issuance costs, was $1,130.5 million. Refer to Note 9, Convertible Senior Notes, in the Notes to Consolidated Financial Statements included in our Fiscal 2022 Form 10-K for further information on the Notes. During the three and nine months ended April 30, 2023, the conditions allowing holders of the Notes to convert were not met. During the three months ended April 30, 2023, we entered into interest rate swap contracts designated as fair value hedges of certain of our Notes. For further information refer to Note 8, Derivative Instruments. The net carrying amount of the liability component of the Notes consisted of the following: April 30, July 31, 2023 2022 (in thousands) Principal amount $ 1,149,993 $ 1,149,995 Less: Unamortized debt discount (1) — 172,169 Unamortized debt issuance costs (1) 8,503 9,152 Hedge accounting fair value adjustments 650 — Total $ 1,140,840 $ 968,674 (1) Effective August 1, 2022, we adopted ASU 2020-06 using the modified retrospective method under which prior period amounts have not been adjusted. The adoption of this standard resulted in the elimination of the debt discount and related amortization as interest expense and the classification of the portion of the debt issuance costs initially allocated to equity within the carrying amount of our convertible senior notes, which is recognized as interest expense post adoption of the standard. The following table sets forth total interest expense recognized related to the Notes: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 (in thousands) Contractual interest expense $ 359 $ 359 $ 1,078 $ 1,078 Amortization of debt discount (1) — 13,186 — 38,971 Amortization of debt issuance costs (1) 974 701 2,919 2,072 Total $ 1,333 $ 14,246 $ 3,997 $ 42,121 (1) The decrease in total interest expense for the three and nine months ended April 30, 2023, was due to the derecognition of unamortized debt discount partially offset by the increase in the amortization of issuance costs previously recognized in equity. These changes were the result of adoption of ASU 2020-06, as described in Note 1, Business and Summary of Significant Accounting Policies. The total fair value of the Notes was $1,129.7 million and $1,418.5 million as of April 30, 2023 and July 31, 2022, respectively. The fair value was determined based on the closing trading price per $1,000 of the Notes as of the last day of trading for the period. We consider the fair value of the Notes as of April 30, 2023 to be a Level II measurement as they are not actively traded. The fair value of the Notes is primarily affected by the trading price of our common stock and market interest rates. In connection with the pricing of the Notes, we entered into capped call transactions with the option counterparties (the "Capped Calls"). The Capped Calls each have an initial strike price of $150.80 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have an initial cap price of $246.76 per share, subject to certain adjustments. The Capped Calls are generally expected to reduce potential dilution to our common stock upon any conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of the converted Notes, as the case may be, with such reduction and/or offset subject to a cap. During the three and nine months ended April 30, 2023 and 2022 , we have not exercised any Capped Call options. Refer to Note 9, Convertible Senior Notes, in the Notes to Consolidated Financial Statements included in our Fiscal 2022 Form 10-K for further information on the Capped Calls.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Apr. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Non-cancelable Purchase Obligations In the normal course of business, we enter into non-cancelable purchase commitments with various third parties to purchase products and services such as technology equipment, subscription-based cloud service arrangements, corporate and marketing events and consulting services. During the three and nine months ended April 30, 2023, there have been no material changes outside the ordinary course of business to our non-cancelable purchase commitments from those disclosed in our Fiscal 2022 Form 10-K. Other Commitments As of April 30, 2023 and July 31, 2022, we had outstanding irrevocable standby unsecured letters of credits for an aggregate value of $2.1 million with a bank, which serve as security under certain real estate leases. Legal Matters We are a party to various litigation matters from time to time and subject to claims that arise in the ordinary course of business, including patent, commercial, product liability, employment, class action, whistleblower and other litigation and

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Apr. 30, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Equity Incentive Plan Equity incentive awards which may be granted to eligible participants under our Fiscal Year 2018 Equity Incentive Plan (the "Plan") include restricted stock units, restricted stock, stock options, nonstatutory stock options, stock appreciation rights, performance units and performance shares. Stock Options The activity of stock options for the nine months ended April 30, 2023 consisted of the following: Outstanding Weighted-Average Weighted-Average Aggregate (in thousands, except per share amounts) Balance as of July 31, 2022 1,673 $ 11.81 2.5 $ 240,286 Exercised (352) 8.95 42,718 Canceled, forfeited or expired (5) 7.61 Balance as of April 30, 2023 1,316 $ 12.60 2.0 $ 101,976 Exercisable and expected to vest as of July 31, 2022 1,501 $ 10.78 2.4 $ 216,539 Exercisable and expected to vest as of April 30, 2023 1,300 $ 12.16 1.9 $ 101,343 The aggregate intrinsic value of the options exercised represents the difference between the fair value of our common stock on the date of exercise and their exercise price. The total intrinsic value of options exercised for the nine months ended April 30, 2023 and 2022 was $42.7 million and $216.5 million, respectively. There were no stock options granted during the periods presented. Restricted Stock Units and Performance Stock Awards The activity of restricted stock units ("RSUs") and performance stock awards ("PSAs") consisted of the following for the nine months ended April 30, 2023: Underlying Shares Weighted-Average Grant Date Fair Value Aggregate (in thousands, except per share data) Balance as of July 31, 2022 7,388 $ 157.17 $ 1,145,526 Granted 5,720 122.82 Vested (2,295) 144.94 322,552 Canceled or forfeited (1,051) 165.52 Balance as of April 30, 2023 9,762 $ 139.02 $ 879,570 As of April 30, 2023, the number of outstanding PSAs for which the performance metrics have not been defined as of such date was not material. These awards are not considered granted for accounting purposes as of April 30, 2023 and accordingly, have been excluded from the above table. Employee Stock Purchase Plan In fiscal 2018, we adopted the Fiscal Year 2018 Employee Stock Purchase Plan (the "ESPP"). During the nine months ended April 30, 2023, employees purchased 0.1 million shares of our common stock under the ESPP at an average purchase price of $99.59 per share, resulting in total cash proceeds of $11.4 million. ESPP employee payroll contributions accrued as of April 30, 2023 and July 31, 2022, were $25.4 million and $4.7 million, respectively, and are included within accrued compensation in the condensed consolidated balance sheets. Payroll contributions accrued as of April 30, 2023 will be used to purchase shares at the end of the current ESPP purchase period ending on June 15, 2023. Payroll contributions ultimately used to purchase shares are reclassified to stockholders’ equity on the purchase date. In December 2022, certain outstanding ESPP offering periods were reset and automatically rolled over into a new ESPP offering period that started on December 15, 2022. The reset was accounted for as a modification, which resulted in incremental stock-based compensation of $8.3 million that will be recognized over the remaining term of the modified ESPP offering periods, ranging from approximately six months to 18 months. The fair value of the purchase right for the ESPP was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Nine Months Ended April 30, 2023 2022 Expected term (in years) 0.5 - 2.0 0.5 - 2.0 Expected stock price volatility 62.4% - 75.9% 44.1% - 57.4% Risk-free interest rate 4.2% - 4.7% 0.1% - 0.7% Dividend yield 0.0% 0.0% Deferred Merger Consideration In February 2023, in connection with a business acquisition, as described in Note 6, Business Combinations, certain former employees of the acquired company who became our employees are entitled to receive deferred merger consideration payable in shares of our common stock with an aggregate fair value of $3.8 million as of the closing date of the acquisition. These awards are subject to future employment services and are recognized as stock-based compensation expense over the requisite service period within research and development expenses in the condensed consolidated statements of operations. The related stock-based compensation expense for the three and nine months ended April 30, 2023 was not material. Departure of the President of the Company In October 2022, our President, who led research and development activities, resigned from his position as President of the Company, but continues to serve as a member of our Board of Directors. In connection with his resignation as President of the Company, we recognized a reversal of stock-based compensation of $9.9 million associated with the cancellation of unvested incentive equity awards, which was recognized in research and development expenses in the condensed consolidated statement of operations for the nine months ended April 30, 2023. Modification of Equity Incentive Awards During the three months ended October 31, 2022, we modified the equity incentive awards of certain employees. In accordance with the accounting for the modification, we recognized stock-based compensation expense of $5.6 million in research and development expenses in the condensed consolidated statement of operations for the nine months ended April 30, 2023. Stock-based Compensation Expense The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 (in thousands) Cost of revenue $ 9,749 $ 5,962 $ 27,591 $ 16,429 Sales and marketing 49,771 50,477 157,619 135,784 Research and development 30,702 29,723 84,238 85,608 General and administrative 16,561 19,692 52,246 56,924 Restructuring and other charges 1,036 — 1,036 — Total $ 107,819 $ 105,854 $ 322,730 $ 294,745 During the three months ended April 30, 2023 and 2022, we capitalized stock-based compensation associated with the development of software for internal-use of $4.1 million and $2.8 million, respectively. During the nine months ended April 30, 2023 and 2022, the amount capitalized was $12.4 million and $8.1 million, respectively.

Income Taxes

Income Taxes	9 Months Ended
	Apr. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our tax provision for interim periods is determined using an estimate of our annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, we update our estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, we make a cumulative adjustment in such period. Our quarterly tax provision, and estimate of our annual effective tax rate, is subject to variation due to several factors, including variability in pre-tax income (or loss), the mix of jurisdictions to which such income relates, changes in how we do business, and tax law developments. Our estimated annual effective tax rate for the year differs from the U.S. statutory rate of 21% as a result of our U.S. losses for which no benefit will be realized, as well as our foreign operations which are subject to tax rates that differ from those in the United States. We recorded provision for income taxes of $6.7 million and a benefit for income taxes of $0.5 million for the three months ended April 30, 2023 and 2022, respectively. We recorded provision for income taxes of $15.1 million and $4.2 million for the nine months ended April 30, 2023 and 2022, respectively. The increase in the provision for income taxes for the nine months ended April 30, 2023 was due to the increase in our pre-tax income in the foreign jurisdictions in which we conduct business and the effects of a tax law change related to mandatory capitalization of rese arch and development expenses for tax years starting January 1, 2022. The provision (benefit) for income taxes for the nine months ended April 30, 2022 includes an income tax benefit of $1.6 million for the refund of withholding taxes related to prior fiscal periods. We are subject to income tax in the United States as well as other tax jurisdictions in which we conduct business. Earnings from our non-U.S. operations are subject to income taxes in the countries in which we operate. The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. We assess our ability to realize the deferred tax assets on a quarterly basis and we establish a valuation allowance if it is more-likely-than-not that some portion of the deferred tax assets will not be realized. We weigh all available positive and negative evidence, including our earnings history and results of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income and tax planning strategies. Due to the weight of objectively verifiable negative evidence, including our history of losses in certain jurisdictions, we believe that it is more likely than not that our U.S. federal, state, and the United Kingdom ("U.K.") deferred tax assets will not be realized. Accordingly, we have maintained a valuation allowance on our U.S. federal, state and U.K. deferred tax assets.

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Apr. 30, 2023
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 (in thousands) Net loss $ (46,046) $ (101,405) $ (171,661) $ (292,626) Weighted-average shares used in computing net loss per share, basic and diluted 145,354 141,422 144,442 140,403 Net loss per share, basic and diluted $ (0.32) $ (0.72) $ (1.19) $ (2.08) Since we have reported net losses for all periods presented, we have excluded all potentially dilutive securities from the calculation of the diluted net loss per share as their effect is antidilutive and accordingly, the basic and diluted net loss per share is the same for all periods presented. Prior to the adoption of ASU 2020-06, we calculated the potential dilutive effect of the Notes under the treasury stock method. As a result, only the amount by which the conversion value exceeded the aggregate principal amount of the Notes (the “conversion spread”) was considered in the diluted earnings per share computation. The conversion spread only had a dilutive impact on diluted net income per share when the average market price of our common stock for a given reporting period exceeded the initial conversion price of $150.80 per share for the Notes. Upon the adoption of ASU 2020-06 on August 1, 2022, we calculated the potential dilutive effect of the Notes under the if-converted method. Under this method, diluted earnings per share is determined by assuming that all of the Notes were converted into shares of our common stock at the beginning of the reporting period. In connection with the issuance of the Notes, we entered into Capped Calls, which were not included for purposes of calculating the number of diluted shares outstanding, as their effect would have been anti-dilutive. The Capped Calls are expected to partially offset the potential dilution to our common stock upon any conversion of the Notes. We have not exercised any of the Capped Calls as of April 30, 2023. The following table summarizes the potentially dilutive securities outstanding as of April 30, 2023 and 2022 that were excluded from the computation of diluted net loss per share as their effect would be antidilutive: April 30, 2023 2022 (in thousands) Unvested RSUs and shares of common stock 8,888 6,384 Stock options 1,316 1,770 Unvested PSAs (1) 1,012 824 Share purchase rights under the ESPP 1,674 317 Notes 7,626 7,626 Total 20,516 16,921 (1)

Business and Summary of Signi_2

Business and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") and applicable regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the applicable required disclosures and regulations of the SEC. Therefore, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's audited consolidated financial statements and related notes in its Annual Report on Form 10-K for the fiscal year ended July 31, 2022 (the "Fiscal 2022 Form 10-K"), as filed with the SEC on September 15, 2022.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal-use software development costs, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value and effective interest rate of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the condensed consolidated financial statements. Due to uncertainty in the macroeconomic environment, including effects of COVID-19 and inflation, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained .
Fiscal Year	Fiscal Year Our fiscal year ends on July 31. References to fiscal 2023, for example, refer to our fiscal year ending July 31, 2023.
Restructuring and Other Charges	Restructuring and Other Charges Restructuring and other charges occur when we commit to a restructuring plan, the restructuring plan identifies all significant actions, the period of time to complete the restructuring plan indicates that significant changes to the restructuring plan are not likely and employees who are impacted have been notified of the pending involuntary termination. A restructuring plan generally includes significant actions involving employee-related severance charges, employee-related benefits, stock-based compensation expense related to the modification of equity incentive awards and other charges associated with the restructuring (the "restructuring charges"). Restructuring charges are accrued in the period in which it is probable that the employees are entitled to the restructuring benefits and the amounts can be reasonably estimated. Restructuring charges are recorded within restructuring and other charges in the condensed consolidated statement of operations. The restructuring liability accrued but not paid at the end of the reporting period is included within accrued compensation in the condensed consolidated balance sheets.
Derivative Instruments	Derivative Instruments We enter into foreign currency forward contracts, a portion of which we designate as cash flow hedges, in order to manage the volatility of cash flows that relate to our cost of revenues and operating expenses denominated in foreign currencies. Gains or losses related to our cash flow hedges are recorded as a component of accumulated other comprehensive income (loss) ("AOCI") in the condensed consolidated statements of stockholders' equity until the forecasted transaction occurs in earnings. When the forecasted transaction occurs, the related gains and losses are reclassified into earnings within the financial statement line item associated with the underlying hedged transaction. If the underlying hedged transaction does not occur, or it becomes probable that the hedged transaction will not occur, the cumulative unrealized gain or loss is reclassified immediately from AOCI into earnings within the financial statement line item associated with the underlying hedged transaction. We also use interest rate swaps to economically convert a certain tranche of our fixed interest rate convertible senior notes to floating interest rates, in order to match the floating rate nature of a portion of our cash, cash equivalents, and short-term investments. These interest rate swaps are designated as fair value hedges, and changes in fair value of the interest rate swaps offset the changes in fair market value of the convertible senior notes due to benchmark interest rate movements. Gains or losses related to our fair value hedges are included within interest expense in the condensed consolidated statement of operations in the period of change together with the offsetting loss or gain on the hedged item attributed to the risk being hedged. We recognize changes in the fair value of non-designated derivative instruments within other expense, net in the condensed consolidated statements of operations in the same period that the fair value measurement occurs. We measure hedge effectiveness using regression analysis at hedge inception and periodically thereafter. We include time value in our effectiveness assessment. All of our derivative instruments are measured at fair value. We have elected to present the derivative assets and derivative liabilities on a gross basis on the unaudited condensed consolidated balance sheets. Derivative instruments are classified in the condensed consolidated statements of cash flows as cash from operating activities, which reflect the classification of the underlying hedged transactions.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting PronouncementsIn June 2020, the Financial Accounting Standard Board ("FASB") issued Accounting Standard Update ("ASU") No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) ("ASU 2020-06"). This standard removes the separation model for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. Such convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. We adopted this standard effective on August 1, 2022, the beginning of fiscal 2023, using the modified retrospective method. In accordance with the adoption of ASU 2020-06 and using the modified retrospective method, prior period amounts have not been adjusted. This standard resulted in our convertible senior notes being accounted for as a single unit of debt and we will no longer be required to record the conversion feature in equity. This further eliminated the need for amortization of the debt discount as interest expense and the portion of the issuance costs initially allocated to equity is now classified as debt and amortized as interest expense. As of August 1, 2022, the adoption of this new standard resulted in an increase of $169.9 million to the carrying amount of the convertible senior notes, a decrease of $273.7 million to additional paid-in capital and a cumulative-effect adjustment of $103.8 million to accumulated deficit. Prior to the adoption of this standard, we used the treasury stock method to calculate the potentially diluted effect of the convertible senior notes; however, upon adoption of this standard we are required to use the if-converted method. Accordingly, to account for the potentially diluted shares related to the convertible senior notes under a net income position, we are required to add back the related interest expense to the net income and include approximately 7.63 million shares related to the convertible senior notes. Since we have reported net losses for all periods presented, the convertible senior notes were determined to be anti-dilutive and therefore had no impact to the diluted net loss per share for all periods presented.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Apr. 30, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use our cloud platform: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 Amount % Revenue Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except per percentage data) United States $ 212,454 51 % $ 141,109 49 % $ 581,477 50 % $ 379,940 49 % Europe, Middle East and Africa 128,964 31 % 95,933 33 % 370,713 32 % 264,656 34 % Asia Pacific 62,928 15 % 42,003 15 % 172,785 15 % 109,083 14 % Other 14,454 3 % 7,762 3 % 36,971 3 % 19,208 3 % Total $ 418,800 100 % $ 286,807 100 % $ 1,161,946 100 % $ 772,887 100 % The following table summarizes the revenue from contracts by type of customer: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 Amount % Revenue Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except per percentage data) Channel partners $ 383,222 92 % $ 266,258 93 % $ 1,070,744 92 % $ 720,809 93 % Direct customers 35,578 8 % 20,549 7 % 91,202 8 % 52,078 7 % Total $ 418,800 100 % $ 286,807 100 % $ 1,161,946 100 % $ 772,887 100 %
Schedule of Capitalized Contract Cost	The activity of the deferred contract acquisition costs consisted of the following: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 (in thousands) Beginning balance $ 315,151 $ 234,505 $ 297,002 $ 207,030 Capitalization of contract acquisition costs 46,364 40,549 110,566 99,062 Amortization of deferred contract acquisition costs (25,315) (17,755) (71,368) (48,793) Ending balance $ 336,200 $ 257,299 $ 336,200 $ 257,299 The outstanding balance of the deferred contract acquisition costs consisted of the following: April 30, 2023 July 31, 2022 (in thousands) Deferred contract acquisition costs, current $ 103,896 $ 86,210 Deferred contract acquisition costs, noncurrent 232,304 210,792 Total deferred contract acquisition costs $ 336,200 $ 297,002

Cash Equivalents and Short-Te_2

Cash Equivalents and Short-Term Investments (Tables)	9 Months Ended
	Apr. 30, 2023
Cash and Cash Equivalents [Abstract]
Schedule of Cash Equivalents and Short-Term Investments	Cash equivalents and short-term investments consisted of the following as of April 30, 2023: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 654,195 $ — $ — $ 654,195 U.S. treasury securities 60,030 1 (10) 60,021 U.S. government agency securities 334,421 1 (30) 334,392 Corporate debt securities 49,203 — — 49,203 Total cash equivalents $ 1,097,849 $ 2 $ (40) $ 1,097,811 Short-term investments: U.S. treasury securities $ 64,664 $ 273 $ — $ 64,937 U.S. government agency securities 233,168 37 (5,013) 228,192 Corporate debt securities 402,561 673 (3,253) 399,981 Total short-term investments $ 700,393 $ 983 $ (8,266) $ 693,110 Total cash equivalents and short-term investments $ 1,798,242 $ 985 $ (8,306) $ 1,790,921 Cash equivalents and short-term investments consisted of the following as of July 31, 2022: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 247,613 $ — $ — $ 247,613 U.S. treasury securities 202,778 — (70) 202,708 U.S. government agency securities 135,525 2 (38) 135,489 Corporate debt securities 106,272 — — 106,272 Total cash equivalents $ 692,188 $ 2 $ (108) $ 692,082 Short-term investments: U.S. treasury securities $ 96,089 $ 10 $ (251) $ 95,848 U.S. government agency securities 339,957 6 (6,628) 333,335 Corporate debt securities 293,968 — (5,022) 288,946 Total short-term investments $ 730,014 $ 16 $ (11,901) $ 718,129 Total cash equivalents and short-term investments $ 1,422,202 $ 18 $ (12,009) $ 1,410,211
Schedule of Maturities	The amortized cost and fair value of our short-term investments based on their stated maturities consisted of the following as of April 30, 2023: Amortized Fair Value (in thousands) Due within one year $ 356,348 $ 353,380 Due between one to three years 344,045 339,730 Total $ 700,393 $ 693,110
Schedule of Unrealized Loss on Investments	Short-term investments that were in an unrealized loss position as of April 30, 2023 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. government agency securities $ 63,551 $ (49) $ 144,110 $ (4,964) $ 207,661 $ (5,013) Corporate debt securities 85,903 (376) 102,719 (2,877) 188,622 (3,253) Total $ 149,454 $ (425) $ 246,829 $ (7,841) $ 396,283 $ (8,266) Short-term investments that were in an unrealized loss position as of July 31, 2022 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 80,833 $ (251) $ — $ — $ 80,833 $ (251) U.S. government agency securities 230,670 (5,150) 50,134 (1,478) 280,804 (6,628) Corporate debt securities 155,968 (3,947) 71,127 (1,075) 227,095 (5,022) Total $ 467,471 $ (9,348) $ 121,261 $ (2,553) $ 588,732 $ (11,901)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Apr. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets Measured on Recurring Basis	Assets and liabilities that are measured at fair value on a recurring basis as of April 30, 2023, consisted of the following: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 654,195 $ 654,195 $ — $ — U.S. treasury securities 60,021 — 60,021 — U.S. government agency securities 334,392 — 334,392 — Corporate debt securities 49,203 — 49,203 — Total cash equivalents $ 1,097,811 $ 654,195 $ 443,616 $ — Short-term investments: U.S. treasury securities $ 64,937 $ — $ 64,937 $ — U.S. government agency securities 228,192 — 228,192 — Corporate debt securities 399,981 — 399,981 — Total short-term investments $ 693,110 $ — $ 693,110 $ — Total cash equivalents and short-term investments $ 1,790,921 $ 654,195 $ 1,136,726 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 10,782 $ — $ 10,782 $ — Foreign currency contracts assets-noncurrent (2) $ 3,479 $ — $ 3,479 $ — Interest rate contracts assets-noncurrent (2) $ 1,002 $ — $ 1,002 $ — Foreign currency contracts liabilities-current (3) $ 2,425 $ — $ 2,425 $ — Foreign currency contracts liabilities-noncurrent (4) $ 359 $ — $ 359 $ — Interest rate contracts liabilities-current (3) $ 1,598 $ — $ 1,598 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 574 $ — $ 574 $ — Foreign currency contracts liabilities-current (3) $ 1,757 $ — $ 1,757 $ — (1) Included within prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Included within other noncurrent assets in the condensed consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Included within other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2022: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 247,613 $ 247,613 $ — $ — U.S. treasury securities 202,708 — 202,708 — U.S. government agency securities 135,489 — 135,489 — Corporate debt securities 106,272 — 106,272 — Total $ 692,082 $ 247,613 $ 444,469 $ — Short-term investments: U.S. treasury securities $ 95,848 $ — $ 95,848 $ — U.S. government agency securities 333,335 — 333,335 — Corporate debt securities 288,946 — 288,946 — Total $ 718,129 $ — $ 718,129 $ — Total cash equivalents and short-term investments $ 1,410,211 $ 247,613 $ 1,162,598 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 178 $ — $ 178 $ — Foreign currency contract assets-noncurrent (2) $ 17 $ — $ 17 $ — Foreign currency contracts liabilities-current (3) $ 10,921 $ — $ 10,921 $ — Foreign currency contracts liabilities-noncurrent (4) $ 588 $ — $ 588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 452 $ — $ 452 $ — Foreign currency contracts liabilities-current (3) $ 3,427 $ — $ 3,427 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets.
Schedule of Fair Value, Liabilities Measured on Recurring Basis	Assets and liabilities that are measured at fair value on a recurring basis as of April 30, 2023, consisted of the following: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 654,195 $ 654,195 $ — $ — U.S. treasury securities 60,021 — 60,021 — U.S. government agency securities 334,392 — 334,392 — Corporate debt securities 49,203 — 49,203 — Total cash equivalents $ 1,097,811 $ 654,195 $ 443,616 $ — Short-term investments: U.S. treasury securities $ 64,937 $ — $ 64,937 $ — U.S. government agency securities 228,192 — 228,192 — Corporate debt securities 399,981 — 399,981 — Total short-term investments $ 693,110 $ — $ 693,110 $ — Total cash equivalents and short-term investments $ 1,790,921 $ 654,195 $ 1,136,726 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 10,782 $ — $ 10,782 $ — Foreign currency contracts assets-noncurrent (2) $ 3,479 $ — $ 3,479 $ — Interest rate contracts assets-noncurrent (2) $ 1,002 $ — $ 1,002 $ — Foreign currency contracts liabilities-current (3) $ 2,425 $ — $ 2,425 $ — Foreign currency contracts liabilities-noncurrent (4) $ 359 $ — $ 359 $ — Interest rate contracts liabilities-current (3) $ 1,598 $ — $ 1,598 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 574 $ — $ 574 $ — Foreign currency contracts liabilities-current (3) $ 1,757 $ — $ 1,757 $ — (1) Included within prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Included within other noncurrent assets in the condensed consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Included within other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2022: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 247,613 $ 247,613 $ — $ — U.S. treasury securities 202,708 — 202,708 — U.S. government agency securities 135,489 — 135,489 — Corporate debt securities 106,272 — 106,272 — Total $ 692,082 $ 247,613 $ 444,469 $ — Short-term investments: U.S. treasury securities $ 95,848 $ — $ 95,848 $ — U.S. government agency securities 333,335 — 333,335 — Corporate debt securities 288,946 — 288,946 — Total $ 718,129 $ — $ 718,129 $ — Total cash equivalents and short-term investments $ 1,410,211 $ 247,613 $ 1,162,598 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 178 $ — $ 178 $ — Foreign currency contract assets-noncurrent (2) $ 17 $ — $ 17 $ — Foreign currency contracts liabilities-current (3) $ 10,921 $ — $ 10,921 $ — Foreign currency contracts liabilities-noncurrent (4) $ 588 $ — $ 588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 452 $ — $ 452 $ — Foreign currency contracts liabilities-current (3) $ 3,427 $ — $ 3,427 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets.

Property and Equipment and Pu_2

Property and Equipment and Purchased Intangible Assets (Tables)	9 Months Ended
	Apr. 30, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following: April 30, 2023 July 31, 2022 (in thousands) Hosting equipment $ 259,998 $ 191,037 Capitalized internal-use software 108,556 72,267 Computers and equipment 7,026 6,774 Purchased software 1,311 1,311 Furniture and fixtures 1,032 1,022 Leasehold improvements 7,404 7,339 Total property and equipment, gross 385,327 279,750 Less: Accumulated depreciation and amortization (162,526) (119,117) Total property and equipment, net $ 222,801 $ 160,633

Business Combinations (Tables)

Business Combinations (Tables)	9 Months Ended
	Apr. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of Purchase Price Allocation	The allocation of the purchase price consideration consisted of the following: Amount Estimated Useful Life (in thousands) Assets acquired: Cash, cash equivalents and other assets $ 673 Acquired intangible assets: Developed technology 5,100 5 years Deferred tax asset 781 Goodwill 10,645 Total $ 17,199 Liabilities assumed: Accounts payable, accrued expenses and other liabilities $ 692 Total $ 692 Total purchase price consideration $ 16,507

Goodwill and Acquired Intangi_2

Goodwill and Acquired Intangible Assets (Tables)	9 Months Ended
	Apr. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Changes in the carrying amount of goodwill for the nine months ended April 30, 2023 consisted of the following:. Amount (in thousands) Balance as of July 31, 2022 $ 78,547 Goodwill acquired 10,645 Balance as of April 30, 2023 $ 89,192
Schedule of Acquired Intangible Assets	Changes in acquired intangible assets for the nine months ended April 30, 2023 consisted of the following: Gross Carrying Amount Accumulated Amortization Net Carrying Amount July 31, 2022 Additions April 30, 2023 July 31, 2022 Amortization Expense April 30, 2023 July 31, 2022 April 30, 2023 (in thousands) Developed technology $ 48,356 $ 5,100 $ 53,456 $ (18,972) $ (7,522) $ (26,494) $ 29,384 $ 26,962 Customer relationships 3,560 — 3,560 (1,125) (556) (1,681) 2,435 1,879 Total $ 51,916 $ 5,100 $ 57,016 $ (20,097) $ (8,078) $ (28,175) $ 31,819 $ 28,841
Schedule of Future Amortization Expense	Future amortization expense of acquired intangible assets as of April 30, 2023 consisted of the following: Amount Fiscal Year ending July 31, (in thousands) 2023 (remaining three months) $ 2,774 2024 10,515 2025 7,278 2026 5,252 2027 2,428 Thereafter 594 Total $ 28,841

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
	Apr. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Cash Flow Hedges on our Consolidated Statement of Operations	The following table presents information about losses related to our cash flow hedges reclassified from AOCI into the condensed consolidated statement of operations for three and nine months ended April 30, 2023 and 2022 : Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 (in thousands) Classification: Cost of revenue $ 247 $ 66 $ 1,660 $ 136 Sales and marketing 711 1,125 6,764 2,265 Research and development 272 13 1,319 10 General and administrative 71 42 538 66 Total $ 1,301 $ 1,246 $ 10,281 $ 2,477
Schedule of Derivative Instruments Designated as Fair Value Hedges	The following table presents the effect of derivative instruments designated as fair value hedges included within interest expense in the condensed statement of operations, for the three and nine months ended April 30, 2023: Gains (Losses) (in thousands) Interest rate swaps: Hedged items $ 650 Derivatives designated as hedging instruments (596) Total $ 54

Restructuring and Other Charg_2

Restructuring and Other Charges (Tables)	9 Months Ended
	Apr. 30, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Activities	The following table presents the activity of the restructuring liability for the three months ended April 30, 2023: Restructuring Liability (in thousands) Balance as of January 31, 2023 $ — Charges, excluding stock-based compensation expense 5,265 Payments (4,261) Balance as of April 30, 2023 $ 1,004

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	9 Months Ended
	Apr. 30, 2023
Debt Disclosure [Abstract]
Schedule of Convertible Senior Notes	The net carrying amount of the liability component of the Notes consisted of the following: April 30, July 31, 2023 2022 (in thousands) Principal amount $ 1,149,993 $ 1,149,995 Less: Unamortized debt discount (1) — 172,169 Unamortized debt issuance costs (1) 8,503 9,152 Hedge accounting fair value adjustments 650 — Total $ 1,140,840 $ 968,674 (1) Effective August 1, 2022, we adopted ASU 2020-06 using the modified retrospective method under which prior period amounts have not been adjusted. The adoption of this standard resulted in the elimination of the debt discount and related amortization as interest expense and the classification of the portion of the debt issuance costs initially allocated to equity within the carrying amount of our convertible senior notes, which is recognized as interest expense post adoption of the standard. The following table sets forth total interest expense recognized related to the Notes: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 (in thousands) Contractual interest expense $ 359 $ 359 $ 1,078 $ 1,078 Amortization of debt discount (1) — 13,186 — 38,971 Amortization of debt issuance costs (1) 974 701 2,919 2,072 Total $ 1,333 $ 14,246 $ 3,997 $ 42,121 (1) The decrease in total interest expense for the three and nine months ended April 30, 2023, was due to the derecognition of unamortized debt discount partially offset by the increase in the amortization of issuance costs previously recognized in equity. These changes were the result of adoption of ASU 2020-06, as described in Note 1, Business and Summary of Significant Accounting Policies.

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Apr. 30, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Options	The activity of stock options for the nine months ended April 30, 2023 consisted of the following: Outstanding Weighted-Average Weighted-Average Aggregate (in thousands, except per share amounts) Balance as of July 31, 2022 1,673 $ 11.81 2.5 $ 240,286 Exercised (352) 8.95 42,718 Canceled, forfeited or expired (5) 7.61 Balance as of April 30, 2023 1,316 $ 12.60 2.0 $ 101,976 Exercisable and expected to vest as of July 31, 2022 1,501 $ 10.78 2.4 $ 216,539 Exercisable and expected to vest as of April 30, 2023 1,300 $ 12.16 1.9 $ 101,343
Schedule of Restricted Stock Units and Performance Stock Awards Activity	The activity of restricted stock units ("RSUs") and performance stock awards ("PSAs") consisted of the following for the nine months ended April 30, 2023: Underlying Shares Weighted-Average Grant Date Fair Value Aggregate (in thousands, except per share data) Balance as of July 31, 2022 7,388 $ 157.17 $ 1,145,526 Granted 5,720 122.82 Vested (2,295) 144.94 322,552 Canceled or forfeited (1,051) 165.52 Balance as of April 30, 2023 9,762 $ 139.02 $ 879,570
Schedule of ESPP Valuation Assumptions	The fair value of the purchase right for the ESPP was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Nine Months Ended April 30, 2023 2022 Expected term (in years) 0.5 - 2.0 0.5 - 2.0 Expected stock price volatility 62.4% - 75.9% 44.1% - 57.4% Risk-free interest rate 4.2% - 4.7% 0.1% - 0.7% Dividend yield 0.0% 0.0%
Schedule of Allocation of Stock-based Compensation Expense	The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 (in thousands) Cost of revenue $ 9,749 $ 5,962 $ 27,591 $ 16,429 Sales and marketing 49,771 50,477 157,619 135,784 Research and development 30,702 29,723 84,238 85,608 General and administrative 16,561 19,692 52,246 56,924 Restructuring and other charges 1,036 — 1,036 — Total $ 107,819 $ 105,854 $ 322,730 $ 294,745

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Apr. 30, 2023
Earnings Per Share [Abstract]
Schedule of Net Loss Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted net loss per share: Three Months Ended April 30, Nine Months Ended April 30, 2023 2022 2023 2022 (in thousands) Net loss $ (46,046) $ (101,405) $ (171,661) $ (292,626) Weighted-average shares used in computing net loss per share, basic and diluted 145,354 141,422 144,442 140,403 Net loss per share, basic and diluted $ (0.32) $ (0.72) $ (1.19) $ (2.08)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table summarizes the potentially dilutive securities outstanding as of April 30, 2023 and 2022 that were excluded from the computation of diluted net loss per share as their effect would be antidilutive: April 30, 2023 2022 (in thousands) Unvested RSUs and shares of common stock 8,888 6,384 Stock options 1,316 1,770 Unvested PSAs (1) 1,012 824 Share purchase rights under the ESPP 1,674 317 Notes 7,626 7,626 Total 20,516 16,921 (1)

Business and Summary of Signi_3

Business and Summary of Significant Accounting Policies (Details) shares in Thousands, $ in Thousands	Aug. 01, 2022 USD ($) shares	Apr. 30, 2023 USD ($)	Jan. 31, 2023 USD ($)	Jul. 31, 2022 USD ($)	Apr. 30, 2022 USD ($)	Jan. 31, 2022 USD ($)	Jul. 31, 2021 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total carrying value		$ 1,149,993		$ 1,149,995
Cumulative effect adjustment		601,274	$ 528,657	573,300	$ 531,577	$ 539,367	$ 528,895
Number of shares if notes converted (in shares) | shares	7,630
Additional Paid-In Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment		1,660,930	1,547,203	1,590,885	1,450,139	1,341,346	1,131,006
Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment		$ (1,059,700)	$ (1,013,654)	(991,878)	$ (894,226)	$ (792,821)	$ (601,600)
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total carrying value	$ 169,900
Cumulative effect adjustment				(169,899)
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-In Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment	(273,700)			(273,738)
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment	$ 103,800			$ 103,839

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022	Jul. 31, 2022
Concentration Risk [Line Items]
Deferred revenue	$ 1,175.4		$ 1,175.4		$ 1,021.1
Contract with customer, liability, revenue recognized			802.1	$ 502.1
Revenue, remaining performance obligation	3,023		3,023
Accrued sales commissions	$ 33.8		$ 33.8		$ 47.2
Minimum
Concentration Risk [Line Items]
Contract with customer, term of contract			1 year
Maximum
Concentration Risk [Line Items]
Contract with customer, term of contract			3 years
Transferred over Time | Product Concentration Risk | Subscription and Support | Revenue Benchmark
Concentration Risk [Line Items]
Concentration risk percentage	97%	97%	97%	97%

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 418,800	$ 286,807	$ 1,161,946	$ 772,887
Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 418,800	$ 286,807	$ 1,161,946	$ 772,887
Revenue percentage	100%	100%	100%	100%
Revenue Benchmark | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 418,800	$ 286,807	$ 1,161,946	$ 772,887
Revenue percentage	100%	100%	100%	100%
Revenue Benchmark | Customer Concentration Risk | Channel partners
Disaggregation of Revenue [Line Items]
Revenue	$ 383,222	$ 266,258	$ 1,070,744	$ 720,809
Revenue percentage	92%	93%	92%	93%
Revenue Benchmark | Customer Concentration Risk | Direct customers
Disaggregation of Revenue [Line Items]
Revenue	$ 35,578	$ 20,549	$ 91,202	$ 52,078
Revenue percentage	8%	7%	8%	7%
United States | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 212,454	$ 141,109	$ 581,477	$ 379,940
Revenue percentage	51%	49%	50%	49%
Europe, Middle East and Africa | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 128,964	$ 95,933	$ 370,713	$ 264,656
Revenue percentage	31%	33%	32%	34%
Asia Pacific | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 62,928	$ 42,003	$ 172,785	$ 109,083
Revenue percentage	15%	15%	15%	14%
Other | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 14,454	$ 7,762	$ 36,971	$ 19,208
Revenue percentage	3%	3%	3%	3%

Revenue Recognition - Performan

Revenue Recognition - Performance Obligation (Details)	Apr. 30, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-05-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	50%
Recognized transaction price period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-05-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	94%
Recognized transaction price period	3 years

Revenue Recognition - Capitaliz

Revenue Recognition - Capitalized Contract Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022	Jul. 31, 2022
Changes in Capitalized Contract Cost [Roll Forward]
Beginning balance	$ 315,151	$ 234,505	$ 297,002	$ 207,030
Capitalization of contract acquisition costs	46,364	40,549	110,566	99,062
Amortization of deferred contract acquisition costs	(25,315)	(17,755)	(71,368)	(48,793)
Ending balance	336,200	257,299	336,200	257,299
Deferred contract acquisition costs, current	103,896		103,896		$ 86,210
Deferred contract acquisition costs, noncurrent	232,304		232,304		210,792
Total deferred contract acquisition costs	$ 336,200	$ 257,299	$ 336,200	$ 257,299	$ 297,002

Cash Equivalents and Short-Te_3

Cash Equivalents and Short-Term Investments - Schedule of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jul. 31, 2022
Cash equivalents:
Amortized Cost	$ 1,097,849	$ 692,188
Unrealized Gains	2	2
Unrealized Losses	(40)	(108)
Fair Value	1,097,811	692,082
Short-term investments:
Amortized Cost	700,393	730,014
Unrealized Gains	983	16
Unrealized Losses	(8,266)	(11,901)
Fair Value	693,110	718,129
Total cash equivalents and short-term investments, amortized cost	1,798,242	1,422,202
Total cash equivalents and short-term investments, unrealized gains	985	18
Total cash equivalents and short-term investments, unrealized losses	(8,306)	(12,009)
Total cash equivalents and short-term investments	1,790,921	1,410,211
U.S. treasury securities
Short-term investments:
Amortized Cost	64,664	96,089
Unrealized Gains	273	10
Unrealized Losses	0	(251)
Fair Value	64,937	95,848
U.S. government agency securities
Short-term investments:
Amortized Cost	233,168	339,957
Unrealized Gains	37	6
Unrealized Losses	(5,013)	(6,628)
Fair Value	228,192	333,335
Corporate debt securities
Short-term investments:
Amortized Cost	402,561	293,968
Unrealized Gains	673	0
Unrealized Losses	(3,253)	(5,022)
Fair Value	399,981	288,946
Money market funds
Cash equivalents:
Amortized Cost	654,195	247,613
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	654,195	247,613
U.S. treasury securities
Cash equivalents:
Amortized Cost	60,030	202,778
Unrealized Gains	1	0
Unrealized Losses	(10)	(70)
Fair Value	60,021	202,708
U.S. government agency securities
Cash equivalents:
Amortized Cost	334,421	135,525
Unrealized Gains	1	2
Unrealized Losses	(30)	(38)
Fair Value	334,392	135,489
Corporate debt securities
Cash equivalents:
Amortized Cost	49,203	106,272
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	$ 49,203	$ 106,272

Cash Equivalents and Short-Te_4

Cash Equivalents and Short-Term Investments - Schedule of Maturities (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jul. 31, 2022
Amortized Cost
Due within one year	$ 356,348
Due between one to three years	344,045
Amortized Cost	700,393	$ 730,014
Fair Value
Due within one year	353,380
Due between one to three years	339,730
Fair Value	$ 693,110	$ 718,129

Cash Equivalents and Short-Te_5

Cash Equivalents and Short-Term Investments - Schedule of Unrealized Position (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jul. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	$ 149,454	$ 467,471
Less than 12 months, unrealized losses	(425)	(9,348)
Greater than 12 months, fair value	246,829	121,261
Greater than 12 months, unrealized losses	(7,841)	(2,553)
Total fair value	396,283	588,732
Total unrealized losses	(8,266)	(11,901)
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value		80,833
Less than 12 months, unrealized losses		(251)
Greater than 12 months, fair value		0
Greater than 12 months, unrealized losses		0
Total fair value		80,833
Total unrealized losses		(251)
U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	63,551	230,670
Less than 12 months, unrealized losses	(49)	(5,150)
Greater than 12 months, fair value	144,110	50,134
Greater than 12 months, unrealized losses	(4,964)	(1,478)
Total fair value	207,661	280,804
Total unrealized losses	(5,013)	(6,628)
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	85,903	155,968
Less than 12 months, unrealized losses	(376)	(3,947)
Greater than 12 months, fair value	102,719	71,127
Greater than 12 months, unrealized losses	(2,877)	(1,075)
Total fair value	188,622	227,095
Total unrealized losses	$ (3,253)	$ (5,022)

Cash Equivalents and Short-Te_6

Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($) $ in Millions	Apr. 30, 2023	Jul. 31, 2022
Cash and Cash Equivalents [Abstract]
Accrued interest receivable	$ 5.8	$ 1.3
Investment carrying value	$ 6.8	$ 5.1

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jul. 31, 2022
Cash equivalents:
Fair Value	$ 1,097,811	$ 692,082
Short-term investments:
Short-term investments	693,110	718,129
Total cash equivalents and short-term investments	1,790,921	1,410,211
Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	1,097,811	692,082
Short-term investments:
Short-term investments	693,110	718,129
Total cash equivalents and short-term investments	1,790,921	1,410,211
Fair Value, Measurements, Recurring | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Derivative assets-current	10,782	178
Derivative assets-noncurrent	3,479	17
Derivative liabilities-current	2,425	10,921
Derivative liabilities-noncurrent	359	588
Non-designated derivative instruments:
Derivative assets-current	10,782	178
Derivative liabilities-current	2,425	10,921
Fair Value, Measurements, Recurring | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Derivative assets-current	574	452
Derivative liabilities-current	1,757	3,427
Non-designated derivative instruments:
Derivative assets-current	574	452
Derivative liabilities-current	1,757	3,427
Fair Value, Measurements, Recurring | Interest rate contracts assets | Designated as Hedging Instrument
Designated derivative instruments:
Derivative assets-noncurrent	1,002
Derivative liabilities-current	1,598
Non-designated derivative instruments:
Derivative liabilities-current	1,598
Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	654,195	247,613
Short-term investments:
Short-term investments	0	0
Total cash equivalents and short-term investments	654,195	247,613
Fair Value, Measurements, Recurring | Level I | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Derivative assets-current	0	0
Derivative assets-noncurrent	0	0
Derivative liabilities-current	0	0
Derivative liabilities-noncurrent	0	0
Non-designated derivative instruments:
Derivative assets-current	0	0
Derivative liabilities-current	0	0
Fair Value, Measurements, Recurring | Level I | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Derivative assets-current	0	0
Derivative liabilities-current	0	0
Non-designated derivative instruments:
Derivative assets-current	0	0
Derivative liabilities-current	0	0
Fair Value, Measurements, Recurring | Level I | Interest rate contracts assets | Designated as Hedging Instrument
Designated derivative instruments:
Derivative assets-noncurrent	0
Derivative liabilities-current	0
Non-designated derivative instruments:
Derivative liabilities-current	0
Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	443,616	444,469
Short-term investments:
Short-term investments	693,110	718,129
Total cash equivalents and short-term investments	1,136,726	1,162,598
Fair Value, Measurements, Recurring | Level II | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Derivative assets-current	10,782	178
Derivative assets-noncurrent	3,479	17
Derivative liabilities-current	2,425	10,921
Derivative liabilities-noncurrent	359	588
Non-designated derivative instruments:
Derivative assets-current	10,782	178
Derivative liabilities-current	2,425	10,921
Fair Value, Measurements, Recurring | Level II | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Derivative assets-current	574	452
Derivative liabilities-current	1,757	3,427
Non-designated derivative instruments:
Derivative assets-current	574	452
Derivative liabilities-current	1,757	3,427
Fair Value, Measurements, Recurring | Level II | Interest rate contracts assets | Designated as Hedging Instrument
Designated derivative instruments:
Derivative assets-noncurrent	1,002
Derivative liabilities-current	1,598
Non-designated derivative instruments:
Derivative liabilities-current	1,598
Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
Short-term investments:
Short-term investments	0	0
Total cash equivalents and short-term investments	0	0
Fair Value, Measurements, Recurring | Level III | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Derivative assets-current	0	0
Derivative assets-noncurrent	0	0
Derivative liabilities-current	0	0
Derivative liabilities-noncurrent	0	0
Non-designated derivative instruments:
Derivative assets-current	0	0
Derivative liabilities-current	0	0
Fair Value, Measurements, Recurring | Level III | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Derivative assets-current	0	0
Derivative liabilities-current	0	0
Non-designated derivative instruments:
Derivative assets-current	0	0
Derivative liabilities-current	0	0
Fair Value, Measurements, Recurring | Level III | Interest rate contracts assets | Designated as Hedging Instrument
Designated derivative instruments:
Derivative assets-noncurrent	0
Derivative liabilities-current	0
Non-designated derivative instruments:
Derivative liabilities-current	0
U.S. treasury securities
Short-term investments:
Short-term investments	64,937	95,848
U.S. treasury securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	64,937	95,848
U.S. treasury securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
U.S. treasury securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	64,937	95,848
U.S. treasury securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
U.S. government agency securities
Short-term investments:
Short-term investments	228,192	333,335
U.S. government agency securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	228,192	333,335
U.S. government agency securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
U.S. government agency securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	228,192	333,335
U.S. government agency securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
Corporate debt securities
Short-term investments:
Short-term investments	399,981	288,946
Corporate debt securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	399,981	288,946
Corporate debt securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
Corporate debt securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	399,981	288,946
Corporate debt securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
Money market funds
Cash equivalents:
Fair Value	654,195	247,613
Money market funds | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	654,195	247,613
Money market funds | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	654,195	247,613
Money market funds | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	0	0
Money market funds | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
U.S. treasury securities
Cash equivalents:
Fair Value	60,021	202,708
U.S. treasury securities | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	60,021	202,708
U.S. treasury securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	0	0
U.S. treasury securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	60,021	202,708
U.S. treasury securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
U.S. government agency securities
Cash equivalents:
Fair Value	334,392	135,489
U.S. government agency securities | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	334,392	135,489
U.S. government agency securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	0	0
U.S. government agency securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	334,392	135,489
U.S. government agency securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
Corporate debt securities
Cash equivalents:
Fair Value	49,203	106,272
Corporate debt securities | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	49,203	106,272
Corporate debt securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	0	0
Corporate debt securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	49,203	106,272
Corporate debt securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	$ 0	$ 0

Property and Equipment and Pu_3

Property and Equipment and Purchased Intangible Assets - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jul. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 385,327	$ 279,750
Less: Accumulated depreciation and amortization	(162,526)	(119,117)
Total property and equipment, net	222,801	160,633
Hosting equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	259,998	191,037
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	108,556	72,267
Computers and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	7,026	6,774
Purchased software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	1,311	1,311
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	1,032	1,022
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 7,404	$ 7,339

Property and Equipment and Pu_4

Property and Equipment and Purchased Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022	Jul. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Historical cost	$ 57,016		$ 57,016		$ 51,916
Accumulated amortization	28,175		28,175		20,097
Depreciation and amortization expense	14,500	$ 10,400	39,769	$ 29,437
Capitalization of development costs of software for internal-use	107,819	105,854	$ 322,730	294,745
IP Addresses
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life			10 years
Historical cost	8,600		$ 8,600		6,400
Accumulated amortization	1,400		1,400		$ 800
Capitalized internal-use software
Acquired Finite-Lived Intangible Assets [Line Items]
Capitalization of development costs of software for internal-use	$ 2,200	$ 1,200	$ 5,900	$ 3,100

Business Combinations - Narrati

Business Combinations - Narrative (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended
	Feb. 20, 2023	Feb. 28, 2023	Jan. 31, 2022	Apr. 30, 2023	Jul. 31, 2022
Business Acquisition [Line Items]
Goodwill				$ 89,192	$ 78,547
Canonics Security Technologies Ltd
Business Acquisition [Line Items]
Cash consideration	$ 16,500
Goodwill	10,645
Deferred tax asset	800			$ 781
Canonics Security Technologies Ltd | Developed technology
Business Acquisition [Line Items]
Developed technology	$ 5,100	$ 5,100
Developed technology, estimated useful life	5 years	5 years
Business Acquisition 2022
Business Acquisition [Line Items]
Cash consideration			$ 400
Goodwill			800
Purchase price			2,100
Fair value of shares issued			1,700
Deferred tax liability			400
Business Acquisition 2022 | Developed technology
Business Acquisition [Line Items]
Developed technology			$ 1,600
Developed technology, estimated useful life			5 years

Business Combinations - Net Ass

Business Combinations - Net Assets Acquired (Details) - USD ($) $ in Thousands		1 Months Ended
	Feb. 20, 2023	Feb. 28, 2023	Apr. 30, 2023	Jul. 31, 2022
Assets acquired:
Goodwill			$ 89,192	$ 78,547
Canonics Security Technologies Ltd
Assets acquired:
Cash, cash equivalents and other assets	$ 673
Deferred tax asset	800		$ 781
Goodwill	10,645
Total	17,199
Liabilities assumed:
Accounts payable, accrued expenses and other liabilities	692
Total	692
Total purchase price consideration	16,507
Canonics Security Technologies Ltd | Developed technology
Assets acquired:
Developed technology	$ 5,100	$ 5,100
Liabilities assumed:
Estimated Useful Life	5 years	5 years

Goodwill and Acquired Intangi_3

Goodwill and Acquired Intangible Assets - Schedule of Goodwill (Details) $ in Thousands	9 Months Ended
	Apr. 30, 2023 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 78,547
Goodwill acquired	10,645
Goodwill, ending balance	$ 89,192

Goodwill and Acquired Intangi_4

Goodwill and Acquired Intangible Assets - Narrative (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended		9 Months Ended
	Feb. 20, 2023	Feb. 28, 2023	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Amortization expense of acquired intangible assets			$ 3,000	$ 2,200	$ 8,078	$ 6,695
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Amortization expense of acquired intangible assets					$ 7,522
Canonics Security Technologies Ltd | Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Developed technology	$ 5,100	$ 5,100
Developed technology, estimated useful life	5 years	5 years

Goodwill and Acquired Intangi_5

Goodwill and Acquired Intangible Assets - Schedule of Acquired Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022	Jul. 31, 2022
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance			$ 51,916
Additions			5,100
Intangible Assets, Gross, ending balance	$ 57,016		57,016
Accumulated Amortization, beginning balance			(20,097)
Amortization Expense	(3,000)	$ (2,200)	(8,078)	$ (6,695)
Accumulated Amortization, ending balance	(28,175)		(28,175)
Total	28,841		28,841		$ 31,819
Developed technology
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance			48,356
Additions			5,100
Intangible Assets, Gross, ending balance	53,456		53,456
Accumulated Amortization, beginning balance			(18,972)
Amortization Expense			(7,522)
Accumulated Amortization, ending balance	(26,494)		(26,494)
Total	26,962		26,962		29,384
Customer relationships
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance			3,560
Additions			0
Intangible Assets, Gross, ending balance	3,560		3,560
Accumulated Amortization, beginning balance			(1,125)
Amortization Expense			(556)
Accumulated Amortization, ending balance	(1,681)		(1,681)
Total	$ 1,879		$ 1,879		$ 2,435

Goodwill and Acquired Intangi_6

Goodwill and Acquired Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2023 (remaining three months)	$ 2,774
2024	10,515
2025	7,278
2026	5,252
2027	2,428
Thereafter	594
Total	$ 28,841	$ 31,819

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022	Jul. 31, 2022
Derivative [Line Items]
Unrealized losses related to our cash flow hedges			$ 7,400
Gain (loss) recognized on cash flow hedges	$ 817	$ (9,304)	10,797	$ (13,773)
Hedge accounting fair value adjustments	650		650		$ 0
Long-term Debt
Derivative [Line Items]
Hedged liability, fair value hedge	198,500		198,500
Foreign currency contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional amount	170,700		170,700		126,400
Foreign currency contracts | Designated as Hedging Instrument
Derivative [Line Items]
Notional amount	446,100		446,100		$ 293,400
Interest Rate Swap
Derivative [Line Items]
Notional amount	$ 200,000		$ 200,000
Minimum | Foreign currency contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Term of derivative	1 month		1 month
Maximum | Foreign currency contracts
Derivative [Line Items]
Term of derivative			24 months
Maximum | Foreign currency contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Term of derivative		4 months		4 months

Derivative Instruments - Cash F

Derivative Instruments - Cash Flow Hedges on our Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ 1,301	$ 1,246	$ 10,281	$ 2,477
Cost of revenue
Derivative Instruments, Gain (Loss) [Line Items]
Total	247	66	1,660	136
Sales and marketing
Derivative Instruments, Gain (Loss) [Line Items]
Total	711	1,125	6,764	2,265
Research and development
Derivative Instruments, Gain (Loss) [Line Items]
Total	272	13	1,319	10
General and administrative
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ 71	$ 42	$ 538	$ 66

Derivative Instruments - Schedu

Derivative Instruments - Schedule of Derivative Instruments Designated as Fair Value Hedges (Details) - Interest rate swaps: $ in Thousands	3 Months Ended
	Apr. 30, 2023 USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	$ 650
Derivatives designated as hedging instruments	(596)
Total	$ 54

Restructuring and Other Charg_3

Restructuring and Other Charges - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022	Mar. 01, 2023	Jan. 31, 2023
Restructuring Cost and Reserve [Line Items]
Worldwide workforce reduction percentage					3%
Aggregate non-recurring charges					$ 7,000
Charges, excluding stock-based compensation expense	$ 5,265
Stock-based compensation expense	107,819	$ 105,854	$ 322,730	$ 294,745
Accrued restructuring liability	1,004		1,004			$ 0
Restructuring Plan 2023
Restructuring Cost and Reserve [Line Items]
Charges, excluding stock-based compensation expense	6,300
Employee severance and benefit charges	5,300
Stock-based compensation expense	1,000
Restructuring and related cost, expected cost remaining	$ 700		$ 700

Restructuring and Other Charg_4

Restructuring and Other Charges - Schedule of Restructuring Activities (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2023 USD ($)
Restructuring Reserve [Roll Forward]
Beginning balance	$ 0
Charges, excluding stock-based compensation expense	5,265
Payments	(4,261)
Ending balance	$ 1,004

Convertible Senior Notes - Narr

Convertible Senior Notes - Narrative (Details) - USD ($)	Jun. 25, 2020	Apr. 30, 2023	Jul. 31, 2022
Debt Instrument [Line Items]
Proceeds from debt issuance	$ 1,130,500,000
Fair value of notes		$ 1,129,700,000	$ 1,418,500,000
Initial strike price (in dollars per share)	$ 150.80
Initial cap price (in dollars per shares)	$ 246.76
Convertible Senior Notes Due 2025
Debt Instrument [Line Items]
Principal amount	$ 1,150,000,000
Interest rate	0.125%
Convertible Senior Notes, $150 million
Debt Instrument [Line Items]
Principal amount	$ 150,000,000

Convertible Senior Notes - Carr

Convertible Senior Notes - Carrying Amounts (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jul. 31, 2022
Convertible Debt [Abstract]
Principal amount	$ 1,149,993	$ 1,149,995
Unamortized debt discount	0	172,169
Unamortized debt issuance costs	8,503	9,152
Hedge accounting fair value adjustments	650	0
Total	$ 1,140,840	$ 968,674

Convertible Senior Notes - Inte

Convertible Senior Notes - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022
Debt Disclosure [Abstract]
Contractual interest expense	$ 359	$ 359	$ 1,078	$ 1,078
Amortization of debt discount	0	13,186	0	38,971
Amortization of debt issuance costs	974	701	2,919	2,072
Total	$ 1,333	$ 14,246	$ 3,997	$ 42,121

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	Apr. 30, 2023	Jul. 31, 2022
Letter of Credit
Loss Contingencies [Line Items]
Aggregate value of unsecured letters of credits	$ 2.1	$ 2.1

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Stock Options (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended		12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jul. 31, 2022
Outstanding Stock Options
Beginning balance (in shares)	1,673
Exercised (in shares)	(352)
Canceled, forfeited or expired (in shares)	(5)
Ending balance (in shares)	1,316		1,673
Exercisable and expected to vest (in shares)	1,300		1,501
Weighted-Average Exercise Price
Beginning balance (in dollars per share)	$ 11.81
Exercised (in dollars per share)	8.95
Canceled, forfeited or expired (in dollars per share)	7.61
Ending balance (in dollars per share)	12.60		$ 11.81
Exercisable and expected to vest (in dollars per share)	$ 12.16		$ 10.78
Additional Disclosures
Options outstanding, weighted average remaining contractual term	2 years		2 years 6 months
Exercisable and expected to vest, weighted average remaining contractual term	1 year 10 months 24 days		2 years 4 months 24 days
Options outstanding, aggregate intrinsic value	$ 101,976		$ 240,286
Exercised, aggregate intrinsic value	42,718	$ 216,500
Exercisable and expected to vest, aggregate intrinsic value	$ 101,343		$ 216,539

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended			9 Months Ended
	Dec. 31, 2022	Apr. 30, 2023	Oct. 31, 2022	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022	Feb. 28, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercised, aggregate intrinsic value					$ 42,718	$ 216,500
Granted (in shares)					0	0
Incremental compensation cost			$ 5,600
Fair value of contingent consideration							$ 3,800
Reversal of stock-based compensation		$ 107,819		$ 105,854	$ 322,730	$ 294,745
Capitalized stock-based compensation		$ 4,100		$ 2,800	12,400	$ 8,100
President
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reversal of stock-based compensation					$ (9,900)
2018 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average purchase price per share (in dollars per share)		$ 99.59			$ 99.59
Employee Stock | 2018 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued (in shares)					100,000
Cash proceeds from the issuance of common stock					$ 11,400
Accrued compensation		$ 25,400			$ 25,400			$ 4,700
Incremental compensation cost	$ 8,300
Employee Stock | 2018 Employee Stock Purchase Plan | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, weighted-average	6 months
Employee Stock | 2018 Employee Stock Purchase Plan | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, weighted-average	18 months

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of RSU and PSA Activity (Details) - Restricted Stock Units and Performance Stock Awards - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Apr. 30, 2023	Jul. 31, 2022
Underlying Shares
Beginning balance (in shares)	7,388
Granted (in shares)	5,720
Vested (in shares)	(2,295)
Canceled or forfeited (in shares)	(1,051)
Ending balance (in shares)	9,762
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share)	$ 157.17
Granted (in dollars per share)	122.82
Vested (in dollars per share)	144.94
Canceled or forfeited (in shares)	165.52
Ending balance (in dollars per share)	$ 139.02
Aggregate Intrinsic Value
Balance	$ 879,570	$ 1,145,526
Vested	$ 322,552

Stock-Based Compensation - Valu

Stock-Based Compensation - Valuation Assumptions (Details) - Employee Stock	9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected stock price volatility, minimum	62.40%	44.10%
Expected stock price volatility, maximum	75.90%	57.40%
Risk-free interest rate, minimum	4.20%	0.10%
Risk-free interest rate, maximum	4.70%	0.70%
Dividend yield	0%	0%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 months	6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	2 years	2 years

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 107,819	$ 105,854	$ 322,730	$ 294,745
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	9,749	5,962	27,591	16,429
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	49,771	50,477	157,619	135,784
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	30,702	29,723	84,238	85,608
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	16,561	19,692	52,246	56,924
Restructuring and other charges
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 1,036	$ 0	$ 1,036	$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022
Income Tax Disclosure [Abstract]
Provision (benefit) for income taxes	$ 6,685	$ (490)	$ 15,123	$ 4,150
Refund for previously withheld withholding taxes				$ 1,600

Net Loss Per Share - Net Loss P

Net Loss Per Share - Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2023	Apr. 30, 2022
Earnings Per Share [Abstract]
Net loss, basic	$ (46,046)	$ (101,405)	$ (171,661)	$ (292,626)
Net loss, diluted	$ (46,046)	$ (101,405)	$ (171,661)	$ (292,626)
Weighted-average shares used in computing net loss per share, basic (in shares)	145,354	141,422	144,442	140,403
Weighted-average shares used in computing net loss per share, diluted (in shares)	145,354	141,422	144,442	140,403
Net loss per share, basic (in dollars per share)	$ (0.32)	$ (0.72)	$ (1.19)	$ (2.08)
Net loss per share, diluted (in dollars per share)	$ (0.32)	$ (0.72)	$ (1.19)	$ (2.08)

Net Loss Per Share - Narrative

Net Loss Per Share - Narrative (Details)	Apr. 30, 2023 $ / shares
Earnings Per Share [Abstract]
Conversion price (in dollars per share)	$ 150.80

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities Excluded from Computation (Details) - shares shares in Thousands	9 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	20,516	16,921
Unvested RSUs and shares of common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	8,888	6,384
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,316	1,770
Unvested PSAs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,012	824
Number of unvested PSAs as a percentage of target	100%	100%
Share purchase rights under the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,674	317
Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	7,626	7,626